Publications
Orthostatic hypertension: the forgotten phenotype
Blood Press, 33 (1), 2431565
DOI 10.1080/08037051.2024.2431565, PubMed 39584479
Should treatment of 'elevated' blood pressure, especially in older people, be based on global risk estimation?
Blood Press, 33 (1), 2430228
DOI 10.1080/08037051.2024.2430228, PubMed 39564976
Intestinal fatty acid binding protein is associated with coronary artery disease in long-term type 1 diabetes-the Dialong study
Cardiovasc Diabetol, 23 (1), 419
DOI 10.1186/s12933-024-02509-3, PubMed 39563343
Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy
Eur Heart J Qual Care Clin Outcomes (in press)
DOI 10.1093/ehjqcco/qcae099, PubMed 39562279
Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses
J Prev Alzheimers Dis, 11 (6), 1634-1646
DOI 10.14283/jpad.2024.156, PubMed 39559876
Transient changes in L-arginine, asymmetric and symmetric dimethyl arginine in triathletes following Norseman Xtreme Triathlon
Front Physiol, 15, 1451038
DOI 10.3389/fphys.2024.1451038, PubMed 39493861
Gut dysbiosis and neutrophil extracellular traps in chronic heart failure
Int J Cardiol, 419, 132689
DOI 10.1016/j.ijcard.2024.132689, PubMed 39489348
Impact of sex-specific thresholds for low flow in assessment of prognosis in concordantly and discordantly graded aortic valve stenosis
Eur Heart J Cardiovasc Imaging (in press)
DOI 10.1093/ehjci/jeae272, PubMed 39467305
Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: A nationwide cohort study 2013-2022
Eur Heart J Acute Cardiovasc Care (in press)
DOI 10.1093/ehjacc/zuae121, PubMed 39441985
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study
J Diabetes Res, 2024, 6142211
DOI 10.1155/2024/6142211, PubMed 39430801
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI
Int J Cardiol, 418, 132613
DOI 10.1016/j.ijcard.2024.132613, PubMed 39374793
Moral distress and protective work environment for healthcare workers during public health emergencies
BMC Med Ethics, 25 (1), 103
DOI 10.1186/s12910-024-01098-w, PubMed 39354454
General Principles, Etiologies, Evaluation, and Management in Older Adults
Clin Geriatr Med, 40 (4), 551-571
DOI 10.1016/j.cger.2024.04.008, PubMed 39349031
Correction: Alveolar echinococcosis
Tidsskr Nor Laegeforen, 144
DOI 10.4045/tidsskr.24.0494, PubMed 39319794
Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling
Biochem Biophys Res Commun, 733, 150706
DOI 10.1016/j.bbrc.2024.150706, PubMed 39305571
Intestinal fatty acid binding protein is associated with infarct size and cardiac function in acute heart failure following myocardial infarction
Open Heart, 11 (2)
DOI 10.1136/openhrt-2024-002868, PubMed 39277188
Lipid-lowering therapy after acute coronary syndromes: a multinational European survey
Coron Artery Dis (in press)
DOI 10.1097/MCA.0000000000001420, PubMed 39263716
Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery?
Eur Heart J Acute Cardiovasc Care, 13 (9), 670-671
DOI 10.1093/ehjacc/zuae101, PubMed 39257308
Alveolar echinococcosis
Tidsskr Nor Laegeforen, 144 (10)
DOI 10.4045/tidsskr.24.0121, PubMed 39254012
The NORwegian atrial fibrillation self-SCREENing (NORSCREEN) trial: rationale and design of a randomized controlled trial
Europace, 26 (10)
DOI 10.1093/europace/euae228, PubMed 39248170
Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size
JACC Adv, 3 (9), 101193
DOI 10.1016/j.jacadv.2024.101193, PubMed 39247678
Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study
Blood Press, 33 (1), 2394448
DOI 10.1080/08037051.2024.2394448, PubMed 39241222
Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?
Kardiol Pol (in press)
DOI 10.33963/v.phj.102335, PubMed 39240921
Reply: Probing the Anthracycline-Induced Myocardial Injury: A Glimpse Through the Lens of the PRADA Trial
JACC CardioOncol, 6 (4), 630
DOI 10.1016/j.jaccao.2024.05.010, PubMed 39239351
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
Eur Heart J Cardiovasc Pharmacother, 10 (7), 614-645
DOI 10.1093/ehjcvp/pvae064, PubMed 39237457
Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden
J Am Coll Cardiol, 84 (13), 1149-1159
DOI 10.1016/j.jacc.2024.07.006, PubMed 39230547
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials
Eur Heart J (in press)
DOI 10.1093/eurheartj/ehae596, PubMed 39222018
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Matrix Biol, 134, 1-22
DOI 10.1016/j.matbio.2024.08.008, PubMed 39214156
Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction
Int J Mol Sci, 25 (16)
DOI 10.3390/ijms25169014, PubMed 39201700
Usefulness of measuring the serum concentration of antihypertensive drugs in uncontrolled hypertension
Tidsskr Nor Laegeforen, 144 (9)
DOI 10.4045/tidsskr.24.0167, PubMed 39167005
[Not Available]
Tidsskr Nor Laegeforen, 144
DOI 10.4045/tidsskr.24.0407, PubMed 39149754
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Eur J Heart Fail, 26 (10), 2055-2076
DOI 10.1002/ejhf.3340, PubMed 39087551
Elective direct current cardioversion of atrial fibrillation - silent brain infarction and health related quality of life
Cardiology (in press)
DOI 10.1159/000540007, PubMed 39025051
Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) - A pilot study protocol
MethodsX, 13, 102810
DOI 10.1016/j.mex.2024.102810, PubMed 39022178
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA
J Am Coll Cardiol, 84 (4), 354-364
DOI 10.1016/j.jacc.2024.05.002, PubMed 39019530
The Interplay of Atherothrombotic Factors and the Evolving Landscape of Atherosclerotic Cardiovascular Disease: Comprehensive Insights from Recent Studies
Anatol J Cardiol, 28 (8), 375-80 (in press)
DOI 10.14744/AnatolJCardiol.2024.4632, PubMed 39011832
Selenoprotein P increases upon selenium and coenzyme Q10 supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
Free Radic Biol Med, 222, 403-413
DOI 10.1016/j.freeradbiomed.2024.06.027, PubMed 38960007
Effects of mild hypercapnia on myocardial injury after out-of-hospital cardiac arrest. A sub-study of the TAME trial
Resuscitation, 201, 110295
DOI 10.1016/j.resuscitation.2024.110295, PubMed 38936652
[Not Available]
Tidsskr Nor Laegeforen, 144 (8)
DOI 10.4045/tidsskr.24.0227, PubMed 38934310
Imaging features for the identification of atrial fibrillation in cryptogenic stroke patients
J Neurol, 271 (8), 5343-5356
DOI 10.1007/s00415-024-12397-y, PubMed 38904781
Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery
Eur Heart J, 45 (28), 2478-2492
DOI 10.1093/eurheartj/ehae363, PubMed 38888906
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
Eur J Heart Fail, 26 (7), 1454-1479
DOI 10.1002/ejhf.3264, PubMed 38837573
Links Between Adipose Tissue Gene Expression of Gut Leakage Markers, Circulating Levels, Anthropometrics, and Diet in Patients with Coronary Artery Disease
Diabetes Metab Syndr Obes, 17, 2177-2190
DOI 10.2147/DMSO.S438818, PubMed 38827167
Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study
Eur Heart J Digit Health, 5 (3), 371-378
DOI 10.1093/ehjdh/ztae026, PubMed 38774377
Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality
PLoS One, 19 (5), e0302732
DOI 10.1371/journal.pone.0302732, PubMed 38739599
Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial
Hypertension, 81 (7), 1628-1636
DOI 10.1161/HYPERTENSIONAHA.124.22832, PubMed 38716657
Supplementation with selenium and coenzyme Q10 in an elderly Swedish population low in selenium - positive effects on thyroid hormones, cardiovascular mortality, and quality of life
BMC Med, 22 (1), 191
DOI 10.1186/s12916-024-03411-1, PubMed 38714999
Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial
Am J Hypertens, 37 (10), 826-836
DOI 10.1093/ajh/hpae059, PubMed 38713475
Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 10 (6), 515-525
DOI 10.1093/ehjcvp/pvae032, PubMed 38702844
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern
J Hypertens, 42 (6), 966-967
DOI 10.1097/HJH.0000000000003735, PubMed 38690902
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes
Thromb Res, 238, 60-66
DOI 10.1016/j.thromres.2024.04.027, PubMed 38676967
Effects on physical activity, physical fitness and well-being in a 36-months randomized controlled study, comparing a multimodal hospital-based intervention programme for primary cardiovascular prevention with usual care
BMC Cardiovasc Disord, 24 (1), 225
DOI 10.1186/s12872-024-03892-1, PubMed 38664620
Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event
Atherosclerosis, 393, 117550
DOI 10.1016/j.atherosclerosis.2024.117550, PubMed 38657552
Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Open, 4 (2), oeae011
DOI 10.1093/ehjopen/oeae011, PubMed 38628674
The REDUCE-AMI trial: an important step in cardiovascular drug de-prescription
Eur Heart J Acute Cardiovasc Care, 13 (4), 370-372
DOI 10.1093/ehjacc/zuae049, PubMed 38608152
The Nordic Cardio-Oncology Society: mission and future goals
Eur Heart J, 45 (21), 1869-1871
DOI 10.1093/eurheartj/ehae014, PubMed 38607440
The role of β-blockers in medical treatment
Curr Med Res Opin, 40 (sup1), 1-2
DOI 10.1080/03007995.2024.2324138, PubMed 38597062
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm
Intern Emerg Med, 19 (6), 1537-1548
DOI 10.1007/s11739-024-03590-y, PubMed 38594458
Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial
Int J Telemed Appl, 2024, 4080415
DOI 10.1155/2024/4080415, PubMed 38567031
Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
Am Heart J Plus, 24, 100228
DOI 10.1016/j.ahjo.2022.100228, PubMed 38560636
Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?
Blood Press, 33 (1), 2329571
DOI 10.1080/08037051.2024.2329571, PubMed 38555859
Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Pharmaceuticals (Basel), 17 (3)
DOI 10.3390/ph17030267, PubMed 38543053
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction
JACC CardioOncol, 6 (1), 83-95
DOI 10.1016/j.jaccao.2023.10.008, PubMed 38510299
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
Hypertension, 81 (5), 1021-1030
DOI 10.1161/HYPERTENSIONAHA.124.22821, PubMed 38477109
High Diagnostic Accuracy of Long-Term Electrocardiogram Interpretation by General Practitioners
Int J Telemed Appl, 2024, 6624344
DOI 10.1155/2024/6624344, PubMed 38425473
Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae086, PubMed 38416125
Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Am J Med, 137 (6), 520-528.e13
DOI 10.1016/j.amjmed.2024.02.005, PubMed 38387539
Survival of the strongest: can muscular strength measurements be used in prevention of heart failure in patients with acute coronary syndromes?
Eur J Prev Cardiol, 31 (7), 832-833
DOI 10.1093/eurjpc/zwae047, PubMed 38381591
[Premature mortality from noncommunicable diseases]
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0849, PubMed 38349090
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
Genome Med, 16 (1), 27
DOI 10.1186/s13073-024-01296-6, PubMed 38331891
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
J Am Coll Cardiol, 83 (6), 652-664
DOI 10.1016/j.jacc.2023.11.029, PubMed 38325990
Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment
Mol Biol Rep, 51 (1), 280
DOI 10.1007/s11033-024-09255-5, PubMed 38324186
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort
Int J Cardiol, 400, 131809
DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129
Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data
Clin Cardiol, 47 (1), e24216
DOI 10.1002/clc.24216, PubMed 38269628
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
Eur J Intern Med, 121, 4-8
DOI 10.1016/j.ejim.2023.12.015, PubMed 38216445
Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
ESC Heart Fail, 11 (2), 871-876
DOI 10.1002/ehf2.14645, PubMed 38204282
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
Eur Heart J Acute Cardiovasc Care, 13 (1), 173-180
DOI 10.1093/ehjacc/zuad158, PubMed 38170562
Vitamin K and Calcium Chelation in Vascular Health
Biomedicines, 11 (12)
DOI 10.3390/biomedicines11123154, PubMed 38137375
Prognostic utility and characterization of left ventricular hypertrophy using global thickness
Sci Rep, 13 (1), 22806
DOI 10.1038/s41598-023-48173-7, PubMed 38129418
Medical Measures in Hypertensives Considered Resistant
Am J Hypertens, 37 (5), 307-317
DOI 10.1093/ajh/hpad118, PubMed 38124494
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
Matrix Biol Plus, 19-20, 100135
DOI 10.1016/j.mbplus.2023.100135, PubMed 38076279
Extract from the 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery - Patient Blood Management
Blood Transfus, 22 (2), 122-129
DOI 10.2450/BloodTransfus.708, PubMed 38063786
European Society of Cardiology Core Curriculum for cardio-oncology
Eur J Heart Fail, 26 (4), 754-771
DOI 10.1002/ejhf.3102, PubMed 38059343
Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
Clin Kidney J, 16 (12), 2357-2364
DOI 10.1093/ckj/sfad231, PubMed 38046011
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry
Int J Cardiol Heart Vasc, 49, 101302
DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
Eur Heart J Cardiovasc Pharmacother, 10 (3), 175-183
DOI 10.1093/ehjcvp/pvad093, PubMed 38017624
The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease
Clin Biochem, 123, 110688
DOI 10.1016/j.clinbiochem.2023.110688, PubMed 37995847
How can we improve the follow-up of patients with heart failure?
Tidsskr Nor Laegeforen, 143 (17)
DOI 10.4045/tidsskr.23.0735, PubMed 37987060
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
N Engl J Med, 390 (2), 107-117
DOI 10.1056/NEJMoa2310234, PubMed 37952132
Outcome prediction in comatose cardiac arrest patients with initial shockable and non-shockable rhythms
Acta Anaesthesiol Scand, 68 (2), 263-273
DOI 10.1111/aas.14337, PubMed 37876138
The current best drug treatment for hypertensive heart failure with preserved ejection fraction
Eur J Intern Med, 120, 3-10
DOI 10.1016/j.ejim.2023.10.008, PubMed 37865559
Transcranial Doppler during the first week after cardiac arrest and association with 6-month outcomes
Front Neurol, 14, 1222401
DOI 10.3389/fneur.2023.1222401, PubMed 37859655
Anticoagulation in cancer-associated thrombosis: how long should the therapy be?
Eur Heart J Cardiovasc Pharmacother, 10 (1), 3-4
DOI 10.1093/ehjcvp/pvad075, PubMed 37827545
Randomized Clinical Outcome Trials in Hypertension
Hypertension, 81 (1), 17-23
DOI 10.1161/HYPERTENSIONAHA.123.21725, PubMed 37795644
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
Int J Mol Sci, 24 (18)
DOI 10.3390/ijms241814143, PubMed 37762446
Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD
J Transl Med, 21 (1), 644
DOI 10.1186/s12967-023-04518-4, PubMed 37730614
How to optimize the use of diuretics in patients with heart failure?
Kardiol Pol, 81 (10), 944-949
DOI 10.33963/v.kp.97315, PubMed 37718589
Cardiovascular changes induced by targeted mild hypercapnia after out of hospital cardiac arrest. A sub-study of the TAME cardiac arrest trial
Resuscitation, 193, 109970
DOI 10.1016/j.resuscitation.2023.109970, PubMed 37716401
Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy
Am J Ther, 30 (5), e411-e415
DOI 10.1097/MJT.0000000000001622, PubMed 37713684
[Diabetes and chronic kidney disease]
Tidsskr Nor Laegeforen, 143 (12)
DOI 10.4045/tidsskr.22.0822, PubMed 37668137
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovasc Diabetol, 22 (1), 233
DOI 10.1186/s12933-023-01963-9, PubMed 37653496
An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVI
Am Heart J, 265, 225-232
DOI 10.1016/j.ahj.2023.08.010, PubMed 37634655
OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
N Engl J Med, 389 (16), 1477-1487
DOI 10.1056/NEJMoa2307770, PubMed 37634149
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
Clin Res Cardiol, 113 (6), 822-830
DOI 10.1007/s00392-023-02268-3, PubMed 37608126
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
Open Heart, 10 (2)
DOI 10.1136/openhrt-2023-002301, PubMed 37591633
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence
Am J Hypertens, 37 (1), 1-14
DOI 10.1093/ajh/hpad073, PubMed 37551929
Cardiac device infection: removing barriers to timely and adequate treatment
Eur Heart J, 44 (35), 3323-3326
DOI 10.1093/eurheartj/ehad490, PubMed 37529893
Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
Clin Nutr, 42 (9), 1657-1660
DOI 10.1016/j.clnu.2023.07.002, PubMed 37515843
CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries
JACC Cardiovasc Imaging, 16 (12), 1626-1628
DOI 10.1016/j.jcmg.2023.05.024, PubMed 37498255
Evaluation of a Structuralized Sick-Leave Programme Compared with usual Care Sick-Leave Management for Patients after an Acute Myocardial Infarction
J Rehabil Med, 55, jrm4569
DOI 10.2340/jrm.v55.4569, PubMed 37486246
Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?
Eur Heart J Cardiovasc Pharmacother, 9 (5), 401-402
DOI 10.1093/ehjcvp/pvad049, PubMed 37486237
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
Nat Rev Cardiol, 20 (12), 830-844
DOI 10.1038/s41569-023-00901-2, PubMed 37474795
Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial
Cells, 12 (13)
DOI 10.3390/cells12131773, PubMed 37443807
Real-world data show the effect of statins in primary prevention
Eur J Prev Cardiol, 30 (17), 1881-1882
DOI 10.1093/eurjpc/zwad231, PubMed 37439146
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
J Am Coll Cardiol, 82 (2), 89-105
DOI 10.1016/j.jacc.2023.04.051, PubMed 37407118
Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trials
Blood Press, 32 (1), 2226757
DOI 10.1080/08037051.2023.2226757, PubMed 37395100
Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
Am J Hypertens, 36 (10), 536-541
DOI 10.1093/ajh/hpad057, PubMed 37382177
Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly
Antioxidants (Basel), 12 (6)
DOI 10.3390/antiox12061157, PubMed 37371887
Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg
Hypertension, 80 (8), 1739-1748
DOI 10.1161/HYPERTENSIONAHA.123.21454, PubMed 37350267
Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study
Atherosclerosis, 379, 117151
DOI 10.1016/j.atherosclerosis.2023.05.020, PubMed 37349194
A man in his seventies with fatigue and renal failure
Tidsskr Nor Laegeforen, 143 (9)
DOI 10.4045/tidsskr.22.0679, PubMed 37341412
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
Front Cardiovasc Med, 10, 1160030
DOI 10.3389/fcvm.2023.1160030, PubMed 37332580
Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest
N Engl J Med, 389 (1), 45-57
DOI 10.1056/NEJMoa2214552, PubMed 37318140
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
Res Pract Thromb Haemost, 7 (4), 100164
DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
[PCSK9 inhibitors on reimbursable prescription: who is eligible?]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.23.0191, PubMed 37254976
Recurrent pericarditis
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.22.0580, PubMed 37254974
Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland
Basic Clin Pharmacol Toxicol, 133 (2), 168-178
DOI 10.1111/bcpt.13902, PubMed 37230945
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
DOI 10.1093/cvr/cvad078, PubMed 37216909
Uric acid and left ventricular mass in prediction of cardiovascular risk-New insight from the URRAH study
Eur J Intern Med, 114, 45-46
DOI 10.1016/j.ejim.2023.05.016, PubMed 37179137
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Eur Heart J Cardiovasc Pharmacother, 9 (4), 353-70 (in press)
DOI 10.1093/ehjcvp/pvad034, PubMed 37169875
Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
J Neurol, 270 (8), 4049-4059
DOI 10.1007/s00415-023-11680-8, PubMed 37162578
Continue or discontinue aspirin before non-cardiac surgery?
Eur Heart J, 44 (26), 2410
DOI 10.1093/eurheartj/ehad246, PubMed 37155334
The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
Chest, 164 (4), 981-991
DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction
Kardiol Pol, 81 (4), 327-329
DOI 10.33963/KP.a2023.0087, PubMed 37144720
Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group
Scand Cardiovasc J, 57 (1), 31-39
DOI 10.1080/14017431.2022.2112071, PubMed 37141087
Transvenous lead extractions in a single high-volume center over a 24-year period: High success rate and low complication rate
Heart Rhythm O2, 4 (4), 232-240
DOI 10.1016/j.hroo.2023.01.003, PubMed 37124554
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Eur Heart J Cardiovasc Pharmacother, 9 (5), 462-496
DOI 10.1093/ehjcvp/pvad032, PubMed 37120728
The roles of cardiac troponins before non-cardiac surgery
Eur Heart J, 44 (23), 2130-2131
DOI 10.1093/eurheartj/ehad226, PubMed 37098747
Key questions regarding the SYMPLICITY HTN-3 trial
Lancet, 401 (10385), 1336-1337
DOI 10.1016/S0140-6736(23)00340-9, PubMed 37087164
Women's health, cardiovascular risk and hypertension: the perspective still needs to improve
Blood Press, 32 (1), 2193648
DOI 10.1080/08037051.2023.2193648, PubMed 37066492
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
Eur Stroke J, 8 (1), 148-156
DOI 10.1177/23969873221123122, PubMed 37021182
"I've kept going" - a multisite repeated cross-sectional study of healthcare workers' pride in personal performance during the COVID-19 pandemic
BMC Health Serv Res, 23 (1), 322
DOI 10.1186/s12913-023-09246-5, PubMed 37004056
Increased SIRT1 Concentration Following Four Years of Selenium and Q10 Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up-Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial
Antioxidants (Basel), 12 (3)
DOI 10.3390/antiox12030759, PubMed 36979007
Fully digital self-screening for atrial fibrillation with patch electrocardiogram
Europace, 25 (5)
DOI 10.1093/europace/euad075, PubMed 36945146
Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation
BMC Neurol, 23 (1), 115
DOI 10.1186/s12883-023-03155-0, PubMed 36944929
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease
Front Cardiovasc Med, 10, 1055069
DOI 10.3389/fcvm.2023.1055069, PubMed 36937936
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study
Rheumatol Int, 43 (6), 1055-1065
DOI 10.1007/s00296-023-05308-3, PubMed 36933069
RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action
J Am Coll Cardiol, 81 (11), 1130-1132
DOI 10.1016/j.jacc.2022.10.041, PubMed 36922095
Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial
EClinicalMedicine, 58, 101875
DOI 10.1016/j.eclinm.2023.101875, PubMed 36915288
The second strategic reperfusion early after myocardial infarction (STREAM-2) study
Eur Heart J Acute Cardiovasc Care, 12 (4), 219-221
DOI 10.1093/ehjacc/zuad024, PubMed 36895183
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
Eur Heart J Cardiovasc Pharmacother, 9 (3), 271-290
DOI 10.1093/ehjcvp/pvad016, PubMed 36869784
Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study
RMD Open, 9 (1)
DOI 10.1136/rmdopen-2022-002815, PubMed 36828644
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year
Am J Med, 136 (5), 484-488
DOI 10.1016/j.amjmed.2023.01.029, PubMed 36828207
[E. Sverre et al. respond]
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.23.0062, PubMed 36811436
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
Eur J Neurol, 30 (5), 1352-1363
DOI 10.1111/ene.15746, PubMed 36786305
High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
PLoS One, 18 (2), e0281155
DOI 10.1371/journal.pone.0281155, PubMed 36763689
First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant
Scand Cardiovasc J, 57 (1), 2174269
DOI 10.1080/14017431.2023.2174269, PubMed 36734834
Antithrombotic treatment after intracerebral hemorrhage: Surveys among stroke physicians in Scandinavia and the United Kingdom
Health Sci Rep, 6 (1), e1059
DOI 10.1002/hsr2.1059, PubMed 36698713
[2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]
G Ital Cardiol (Rome), 24 (1 Suppl 1), e1-e102
DOI 10.1714/3956.39326, PubMed 36645369
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
Atheroscler Plus, 48, 47-54
DOI 10.1016/j.athplu.2022.03.005, PubMed 36644557
Fibrates: one more lost paradise in lipid treatment
Eur Heart J Cardiovasc Pharmacother, 9 (2), 121
DOI 10.1093/ehjcvp/pvac072, PubMed 36610735
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab, 49 (2), 101418
DOI 10.1016/j.diabet.2022.101418, PubMed 36608816
Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
JACC Cardiovasc Imaging, 16 (1), 128-129
DOI 10.1016/j.jcmg.2022.07.021, PubMed 36599558
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome
J Immunol Res, 2022, 2366695
DOI 10.1155/2022/2366695, PubMed 36582742
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Acute Cardiovasc Care, 11 (12), 939-949
DOI 10.1093/ehjacc/zuac123, PubMed 36574353
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
BMJ, 378, e069048
DOI 10.1136/bmj-2021-069048, PubMed 36562446
Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
J Clin Med, 11 (24)
DOI 10.3390/jcm11247330, PubMed 36555946
Screen-Detected Atrial Fibrillation and "Micro-Atrial Fibrillation" and Risk of Cardiovascular Events after Myocardial Infarction in Elderly Patients
Cardiology, 148 (1), 72-77
DOI 10.1159/000528726, PubMed 36538900
The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
Eur Heart J, 44 (5), 336-337
DOI 10.1093/eurheartj/ehac703, PubMed 36527277
Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair
Adv Sci (Weinh), 10 (5), e2203053
DOI 10.1002/advs.202203053, PubMed 36526599
Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?
Circ Heart Fail, 16 (1), e010222
DOI 10.1161/CIRCHEARTFAILURE.122.010222, PubMed 36524473
Pharmacological treatment of CVD
Eur Heart J Cardiovasc Pharmacother, 9 (1), 1-3
DOI 10.1093/ehjcvp/pvac068, PubMed 36519600
[Checkpoint inhibitor-induced myocarditis]
Tidsskr Nor Laegeforen, 142 (18)
DOI 10.4045/tidsskr.21.0817, PubMed 36511752
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomed Pharmacother, 158, 114064
DOI 10.1016/j.biopha.2022.114064, PubMed 36495662
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Eur Heart J, 44 (4), 262-279
DOI 10.1093/eurheartj/ehac515, PubMed 36477865
Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
Clin Appl Thromb Hemost, 28, 10760296221141893
DOI 10.1177/10760296221141893, PubMed 36474435
To treat or not to treat
Eur Heart J Cardiovasc Pharmacother, 8 (8), 754-755
DOI 10.1093/ehjcvp/pvac062, PubMed 36458860
Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry
Eur Heart J, 44 (2), 142-158
DOI 10.1093/eurheartj/ehac640, PubMed 36452988
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
Eur Heart J Open, 2 (6), oeac070
DOI 10.1093/ehjopen/oeac070, PubMed 36440353
Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area
Open Heart, 9 (2)
DOI 10.1136/openhrt-2022-002159, PubMed 36428084
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes
Lancet Diabetes Endocrinol, 10 (12), 840
DOI 10.1016/S2213-8587(22)00312-6, PubMed 36427519
Personalised cardiovascular disease prevention in the new guidelines
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0508, PubMed 36416647
Changes in circulating sirtuin 1 after bariatric surgery
Nutr Metab Cardiovasc Dis, 32 (12), 2858-2864
DOI 10.1016/j.numecd.2022.09.009, PubMed 36404480
The link between liver fat and cardiometabolic diseases is highlighted by genome-wide association study of MRI-derived measures of body composition
Commun Biol, 5 (1), 1271
DOI 10.1038/s42003-022-04237-4, PubMed 36402844
Metabolic predictors of pain, fatigue, depression and quality of life in people with long-term type 1 diabetes-the Dialong study
Diabet Med, 40 (3), e15009
DOI 10.1111/dme.15009, PubMed 36398424
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension
Blood Press, 32 (1), 1-3
DOI 10.1080/08037051.2022.2142512, PubMed 36369908
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data
J Cardiovasc Magn Reson, 24 (1), 53
DOI 10.1186/s12968-022-00888-8, PubMed 36336693
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
Eur Heart J Qual Care Clin Outcomes, 9 (1), 1-7
DOI 10.1093/ehjqcco/qcac070, PubMed 36316010
Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting
BMC Health Serv Res, 22 (1), 1274
DOI 10.1186/s12913-022-08697-6, PubMed 36271364
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020
ESC Heart Fail, 10 (1), 405-415
DOI 10.1002/ehf2.14206, PubMed 36266969
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
Eur Heart J Acute Cardiovasc Care, 11 (11), 865-874
DOI 10.1093/ehjacc/zuac107, PubMed 36226746
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
Eur Heart J, 43 (37), 3578-3588
DOI 10.1093/eurheartj/ehac426, PubMed 36208161
The new 2022 ESC Guidelines on Cardio-oncology and their impact on the Acute Cardiovascular Care Society
Eur Heart J Acute Cardiovasc Care, 11 (11), 844-849
DOI 10.1093/ehjacc/zuac129, PubMed 36205095
Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding
Eur Heart J Cardiovasc Pharmacother, 8 (7), 645-647
DOI 10.1093/ehjcvp/pvac048, PubMed 36172980
Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
Biomedicines, 10 (9)
DOI 10.3390/biomedicines10092196, PubMed 36140297
Changes in health status and health related quality of life from six months to five years in out-of-hospital cardiac arrest survivors - A NORCAST sub study
Resuscitation, 181, 182-189
DOI 10.1016/j.resuscitation.2022.08.019, PubMed 36084805
Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy
J Am Heart Assoc, 11 (18), e025879
DOI 10.1161/JAHA.121.025879, PubMed 36073648
Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19
Eur Heart J Open, 2 (5), oeac052
DOI 10.1093/ehjopen/oeac052, PubMed 36071696
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care
Eur Heart J Qual Care Clin Outcomes, 9 (4), 331-341
DOI 10.1093/ehjqcco/qcac057, PubMed 36069905
Prevention is still the key to success
Eur Heart J Cardiovasc Pharmacother, 8 (6), 537-538
DOI 10.1093/ehjcvp/pvac046, PubMed 36057770
Guideline-Recommended Time Less Than 90 Minutes From ECG to Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Is Associated with Major Survival Benefits, Especially in Octogenarians: A Contemporary Report in 11 226 Patients from NORIC
J Am Heart Assoc, 11 (17), e024849
DOI 10.1161/JAHA.122.024849, PubMed 36056722
CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
Lancet Digit Health, 4 (10), e757-e764
DOI 10.1016/S2589-7500(22)00151-0, PubMed 36050271
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
J Am Coll Cardiol, 80 (12), 1130-1143
DOI 10.1016/j.jacc.2022.06.037, PubMed 36050227
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
Circulation, 146 (15), 1109-1119
DOI 10.1161/CIRCULATIONAHA.122.061620, PubMed 36031810
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified
Blood Press, 31 (1), 210-224
DOI 10.1080/08037051.2022.2110858, PubMed 36029011
Selenium and Coenzyme Q10 Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial
Nutrients, 14 (16)
DOI 10.3390/nu14163346, PubMed 36014852
TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients-A Possible Link to Clonal Hematopoiesis
Biomedicines, 10 (8)
DOI 10.3390/biomedicines10082027, PubMed 36009574
Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
BMC Prim Care, 23 (1), 214
DOI 10.1186/s12875-022-01824-6, PubMed 36008778
A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
Cardiovasc Drugs Ther, 38 (4), 775-797
DOI 10.1007/s10557-022-07373-5, PubMed 36001200
Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet
Int J Clin Pharmacol Ther, 60 (10), 430-438
DOI 10.5414/CP204271, PubMed 35979901
Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary Syndrome
Am J Med, 135 (11), 1342-1348
DOI 10.1016/j.amjmed.2022.07.022, PubMed 35977606
Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure
Blood Press, 31 (1), 207-209
DOI 10.1080/08037051.2022.2107483, PubMed 35941816
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
Eur Heart J, 43 (37), 3512-3527
DOI 10.1093/eurheartj/ehac294, PubMed 35925556
Toward personalized medicine for cardiovascular pharmacotherapy
Eur Heart J, 43 (45), 4719-4721
DOI 10.1093/eurheartj/ehac413, PubMed 35924414
Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries
Eur Heart J Open, 2 (4), oeac042
DOI 10.1093/ehjopen/oeac042, PubMed 35919580
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions
Blood Press, 31 (1), 164-168
DOI 10.1080/08037051.2022.2095254, PubMed 35876172
Abdominal Adipose Tissue Associates With Adiponectin and TNFα in Middle-Aged Healthy Men
Front Endocrinol (Lausanne), 13, 874977
DOI 10.3389/fendo.2022.874977, PubMed 35872989
Focus on optimizing treatment of coronary heart disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), 431-433
DOI 10.1093/ehjcvp/pvac039, PubMed 35856265
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Eur Heart J Cardiovasc Pharmacother, 8 (7), 738-751
DOI 10.1093/ehjcvp/pvac040, PubMed 35848895
[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]
G Ital Cardiol (Rome), 23 (6 Suppl 1), e3-e115
DOI 10.1714/3808.37926, PubMed 35708476
Blood pressure during moderate or maximal exercise: hardly two sides of the same coin
J Hypertens, 40 (6), 1243-1244
DOI 10.1097/HJH.0000000000003121, PubMed 35703887
Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy
Blood Press, 31 (1), 125-128
DOI 10.1080/08037051.2022.2083578, PubMed 35674494
Focus on different aspects of atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 8 (4), 323-324
DOI 10.1093/ehjcvp/pvac035, PubMed 35674202
[Are doctors the right people to assess driving ability?]
Tidsskr Nor Laegeforen, 142 (8)
DOI 10.4045/tidsskr.22.0329, PubMed 35635419
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial
JAMA Cardiol, 7 (7), 682-689
DOI 10.1001/jamacardio.2022.1166, PubMed 35612866
Exercise-induced change in circulating NT-proBNP could not distinguish between patients with and without coronary artery disease: the CADENCE study
Scand Cardiovasc J, 56 (1), 107-113
DOI 10.1080/14017431.2022.2075562, PubMed 35593516
Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis
Rheumatology (Oxford), 62 (SI2), SI196-SI204
DOI 10.1093/rheumatology/keac293, PubMed 35575380
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Rev Esp Cardiol (Engl Ed), 75 (5), 429
DOI 10.1016/j.rec.2022.04.003, PubMed 35525570
Integrin α11β1 and syndecan-4 dual receptor ablation attenuate cardiac hypertrophy in the pressure overloaded heart
Am J Physiol Heart Circ Physiol, 322 (6), H1057-H1071
DOI 10.1152/ajpheart.00635.2021, PubMed 35522553
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol, 80 (7-8), 741-749
DOI 10.33963/KP.a2022.0117, PubMed 35521719
Future of antithrombotic therapy for heart failure with coronary artery disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), e25
DOI 10.1093/ehjcvp/pvac030, PubMed 35521703
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
EBioMedicine, 80, 104013
DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
JACC CardioOncol, 4 (1), 19-37
DOI 10.1016/j.jaccao.2022.01.101, PubMed 35492815
Coagulation factors XI and XII as possible targets for anticoagulant therapy
Thromb Res, 214, 53-62
DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644
Gene expression of fibrinolytic markers in coronary thrombi
Thromb J, 20 (1), 23
DOI 10.1186/s12959-022-00383-1, PubMed 35488283
Gut Leakage and Cardiac Biomarkers after Prolonged Strenuous Exercise
Med Sci Sports Exerc, 54 (9), 1476-1482
DOI 10.1249/MSS.0000000000002948, PubMed 35482788
Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
Scand J Med Sci Sports, 32 (8), 1170-1181
DOI 10.1111/sms.14172, PubMed 35460300
Effect of Revascularization on Exercise-Induced Changes in Cardiac and Prothrombotic Biomarkers in Patients with Coronary Artery Disease
Clin Appl Thromb Hemost, 28, 10760296221094029
DOI 10.1177/10760296221094029, PubMed 35437054
New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
Eur Heart J Cardiovasc Pharmacother, 8 (3), 213-215
DOI 10.1093/ehjcvp/pvac019, PubMed 35435962
Hypertension management during the COVID-19 pandemic: what can we learn for the future?
Blood Press, 31 (1), 47-49
DOI 10.1080/08037051.2022.2058909, PubMed 35426323
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
PLoS One, 17 (4), e0266615
DOI 10.1371/journal.pone.0266615, PubMed 35404972
Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
Open Heart, 9 (1)
DOI 10.1136/openhrt-2021-001934, PubMed 35387862
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines
Hypertension, 79 (6), 1153-1166
DOI 10.1161/HYPERTENSIONAHA.122.19020, PubMed 35378981
Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1-Hour Algorithm in a Low-Risk Population
J Am Heart Assoc, 11 (7), e024927
DOI 10.1161/JAHA.121.024927, PubMed 35352564
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life Study
Rev Cardiovasc Med, 23 (3), 95
DOI 10.31083/j.rcm2303095, PubMed 35345262
Vascular Function in Norwegian Female Elite Runners: A Cross-Sectional, Controlled Study
Sports (Basel), 10 (3)
DOI 10.3390/sports10030037, PubMed 35324646
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
BMC Cardiovasc Disord, 22 (1), 88
DOI 10.1186/s12872-022-02522-y, PubMed 35247979
[The Journal as a forum for debate on immigration policy?]
Tidsskr Nor Laegeforen, 142 (4)
DOI 10.4045/tidsskr.22.0105, PubMed 35239275
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
Eur J Heart Fail, 24 (5), 782-790
DOI 10.1002/ejhf.2468, PubMed 35239245
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
PLoS One, 17 (2), e0264628
DOI 10.1371/journal.pone.0264628, PubMed 35213675
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial
Open Heart, 9 (1)
DOI 10.1136/openhrt-2021-001892, PubMed 35172988
Do We Really Need Aspirin Loading for STEMI?
Cardiovasc Drugs Ther, 36 (6), 1221-1238
DOI 10.1007/s10557-022-07327-x, PubMed 35171384
Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial
JAMA Cardiol, 7 (4), 435-444
DOI 10.1001/jamacardio.2021.5916, PubMed 35171199
Extreme altitude induces divergent mass reduction of right and left ventricle in mountain climbers
Physiol Rep, 10 (3), e15184
DOI 10.14814/phy2.15184, PubMed 35146955
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
Acta Neurol Scand, 145 (5), 641-646
DOI 10.1111/ane.13590, PubMed 35146751
Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis
Arthritis Rheumatol, 74 (5), 810-817
DOI 10.1002/art.42056, PubMed 35137553
TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients
Coron Artery Dis, 33 (6), 446-455
DOI 10.1097/MCA.0000000000001128, PubMed 35102064
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (4), 406-419
DOI 10.1093/ehjcvp/pvac005, PubMed 35092425
NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease
Front Immunol, 12, 799539
DOI 10.3389/fimmu.2021.799539, PubMed 35069582
A 30th anniversary and a glimpse of the future
Blood Press, 31 (1), 1-3
DOI 10.1080/08037051.2021.2021638, PubMed 35060412
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
J Womens Health (Larchmt), 31 (3), 310-320
DOI 10.1089/jwh.2021.0326, PubMed 35049355
Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19
J Am Heart Assoc, 11 (3), e023473
DOI 10.1161/JAHA.121.023473, PubMed 35048715
Optimizing individual heart failure treatment
Eur Heart J Cardiovasc Pharmacother, 8 (2), 105-107
DOI 10.1093/ehjcvp/pvab087, PubMed 35039827
Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
JACC Cardiovasc Imaging, 15 (4), 607-625
DOI 10.1016/j.jcmg.2021.11.008, PubMed 35033498
The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool
Curr Cardiol Rep, 24 (2), 109-118
DOI 10.1007/s11886-021-01628-7, PubMed 35028816
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials
Clin Cardiol, 45 (1), 101-109
DOI 10.1002/clc.23765, PubMed 35019175
Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study
Rheumatol Int, 42 (7), 1213-1220
DOI 10.1007/s00296-021-05071-3, PubMed 34984516
Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient
Eur Heart J Cardiovasc Pharmacother, 8 (1), 1-3
DOI 10.1093/ehjcvp/pvab078, PubMed 34984441
Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
J Intern Med, 291 (5), 637-647
DOI 10.1111/joim.13442, PubMed 34982486
Cardioprotection in breast cancer patients: one size fits all?
Eur Heart J, 43 (27), 2570-2572
DOI 10.1093/eurheartj/ehab810, PubMed 34951626
Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001884, PubMed 34933965
High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001869, PubMed 34933964
Comments on-The noradrenaline dosing in the new 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Eur Heart J Cardiovasc Pharmacother, 8 (3), E11
DOI 10.1093/ehjcvp/pvab086, PubMed 34918059
Complement ratios C3bc/C3 and sC5b-9/C5 do not increase the sensitivity of detecting acute complement activation systemically
Mol Immunol, 141, 273-279
DOI 10.1016/j.molimm.2021.11.016, PubMed 34906905
Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population-based cohort study in Norway
Fundam Clin Pharmacol, 36 (3), 563-571
DOI 10.1111/fcp.12744, PubMed 34904750
Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
J Acquir Immune Defic Syndr, 89 (1), 77-86
DOI 10.1097/QAI.0000000000002817, PubMed 34878437
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovasc Res, 118 (6), 1385-1412
DOI 10.1093/cvr/cvab342, PubMed 34864874
MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study
J Cardiovasc Magn Reson, 23 (1), 137
DOI 10.1186/s12968-021-00824-2, PubMed 34857009
Cardiac Arrest in a Patient With Arrhythmic Mitral Valve Prolapse Syndrome: Multiple Possible Etiologies
JACC Case Rep, 3 (16), 1769-1773
DOI 10.1016/j.jaccas.2021.08.019, PubMed 34825207
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
J Intern Med, 291 (3), 327-337
DOI 10.1111/joim.13409, PubMed 34820922
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis
Ann Intern Med, 175 (1), 101-113
DOI 10.7326/M21-1499, PubMed 34807719
Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
Kidney Med, 4 (2), 100389
DOI 10.1016/j.xkme.2021.09.006, PubMed 34805967
Adiponectin in relation to exercise and physical performance in patients with type 2 diabetes and coronary artery disease
Adipocyte, 10 (1), 612-620
DOI 10.1080/21623945.2021.1996699, PubMed 34779349
Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology
J Healthc Eng, 2021, 5230947
DOI 10.1155/2021/5230947, PubMed 34765102
One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
Clin Nutr, 40 (12), 5674-5677
DOI 10.1016/j.clnu.2021.10.007, PubMed 34742136
Unsolved pharmacological issues with cardiology
Eur Heart J Cardiovasc Pharmacother, 7 (6), 461-462
DOI 10.1093/ehjcvp/pvab077, PubMed 34734246
Body composition in long-standing juvenile dermatomyositis: associations with disease activity, muscle strength and cardiometabolic measures
Rheumatology (Oxford), 61 (7), 2959-2968
DOI 10.1093/rheumatology/keab805, PubMed 34718443
Attended vs. unattended blood pressure - learnings beyond SPRINT
Blood Press, 30 (6), 439-440
DOI 10.1080/08037051.2021.1995981, PubMed 34714207
The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug
Blood Press, 30 (6), 327-331
DOI 10.1080/08037051.2021.1995975, PubMed 34714185
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
BMJ, 375, e066450
DOI 10.1136/bmj-2021-066450, PubMed 34706884
Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction
Nutrients, 13 (10)
DOI 10.3390/nu13103475, PubMed 34684479
Impact of Selenium on Biomarkers and Clinical Aspects Related to Ageing. A Review
Biomolecules, 11 (10)
DOI 10.3390/biom11101478, PubMed 34680111
The Oslo Ischaemia Study: cohort profile
BMJ Open, 11 (10), e049111
DOI 10.1136/bmjopen-2021-049111, PubMed 34645662
Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection
Blood Press, 30 (5), 267-268
DOI 10.1080/08037051.2021.1975878, PubMed 34586009
Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease
Cells, 10 (9)
DOI 10.3390/cells10092193, PubMed 34571843
Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon
Sports (Basel), 9 (9)
DOI 10.3390/sports9090120, PubMed 34564325
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur J Prev Cardiol, 29 (1), 5-115
DOI 10.1093/eurjpc/zwab154, PubMed 34558602
More knowledge about atrial fibrillation, still we need to learn
Eur Heart J Cardiovasc Pharmacother, 7 (5), 361-362
DOI 10.1093/ehjcvp/pvab067, PubMed 34545933
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis
Clin Res Cardiol, 111 (4), 428-439
DOI 10.1007/s00392-021-01913-z, PubMed 34498169
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 100-103
DOI 10.1093/ehjcvp/pvab063, PubMed 34463331
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur Heart J, 42 (34), 3227-3337
DOI 10.1093/eurheartj/ehab484, PubMed 34458905
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology
Europace, 24 (1), 165-172
DOI 10.1093/europace/euab193, PubMed 34455442
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
Eur Heart J Acute Cardiovasc Care, 10 (8), 947-959
DOI 10.1093/ehjacc/zuab056, PubMed 34453829
Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001720, PubMed 34426527
Icons in Cardiology
Cardiology, 146 (6), 667
DOI 10.1159/000519019, PubMed 34412055
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
Eur Heart J, 42 (39), 4064-4072
DOI 10.1093/eurheartj/ehab506, PubMed 34405870
The Establishment of the Nordic Cardio-Oncology Society
JACC CardioOncol, 2 (2), 333-335
DOI 10.1016/j.jaccao.2020.04.004, PubMed 34396242
"Retained wire femoral lead removal and fibroplasty" for obtaining venous access in patients with refractory venous obstruction
J Cardiovasc Electrophysiol, 32 (10), 2729-2736
DOI 10.1111/jce.15197, PubMed 34374160
Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial
J Am Coll Cardiol, 78 (6), 637-638
DOI 10.1016/j.jacc.2021.06.005, PubMed 34353542
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
EBioMedicine, 70, 103511
DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947
The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
Am Heart J, 241, 92-100
DOI 10.1016/j.ahj.2021.07.007, PubMed 34310907
Cuff-less measurements of blood pressure: are we ready for a change?
Blood Press, 30 (4), 205-207
DOI 10.1080/08037051.2021.1956178, PubMed 34308727
Adherence to pharmacological treatment: how can we improve?
Eur Heart J Cardiovasc Pharmacother, 7 (4), 261-262
DOI 10.1093/ehjcvp/pvab049, PubMed 34298551
Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations
Hypertension, 78 (3), 617-628
DOI 10.1161/HYPERTENSIONAHA.121.17514, PubMed 34275336
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?
Am J Cardiovasc Drugs, 22 (2), 113-115
DOI 10.1007/s40256-021-00488-4, PubMed 34254254
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
Cardiovasc Drugs Ther, 36 (3), 525-532
DOI 10.1007/s10557-021-07224-9, PubMed 34245446
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
Eur Heart J Qual Care Clin Outcomes, 8 (5), 577-587
DOI 10.1093/ehjqcco/qcab048, PubMed 34244745
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
PLoS One, 16 (7), e0253247
DOI 10.1371/journal.pone.0253247, PubMed 34242246
Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective
Hypertension, 78 (2), 555-558
DOI 10.1161/HYPERTENSIONAHA.121.17356, PubMed 34232677
Why we do not need a single independent international hypertension clinical practice guideline
J Hypertens, 39 (11), 2125-2127
DOI 10.1097/HJH.0000000000002940, PubMed 34224539
Transient Reduction of FMD-Response and L-Arginine Accompanied by Increased Levels of E-Selectin, VCAM, and ICAM after Prolonged Strenuous Exercise
Sports (Basel), 9 (6)
DOI 10.3390/sports9060086, PubMed 34204566
[Myhre, Seljeflot and Arnesen respond]
Tidsskr Nor Laegeforen, 141 (10)
DOI 10.4045/tidsskr.21.0470, PubMed 34182730
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (3), 302-310
DOI 10.1093/ehjcvp/pvab048, PubMed 34180504
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
PLoS One, 16 (6), e0253793
DOI 10.1371/journal.pone.0253793, PubMed 34170978
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
Mediators Inflamm, 2021, 5525917
DOI 10.1155/2021/5525917, PubMed 34135690
Complement activation is associated with poor outcome after out-of-hospital cardiac arrest
Resuscitation, 166, 129-136
DOI 10.1016/j.resuscitation.2021.05.038, PubMed 34126135
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
J Hypertens, 39 (8), 1522-1545
DOI 10.1097/HJH.0000000000002910, PubMed 34102660
Novel insights into stroke risk beyond resting and maximal bicycle exercise systolic blood pressure
J Hypertens, 39 (10), 2022-2029
DOI 10.1097/HJH.0000000000002894, PubMed 34102659
Examining the lower range of the association between alcohol intake and risk of incident hospitalization with atrial fibrillation
Int J Cardiol Heart Vasc, 31, 100679
DOI 10.1016/j.ijcha.2020.100679, PubMed 34095445
The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused
Eur J Intern Med, 90, 125-126
DOI 10.1016/j.ejim.2021.05.009, PubMed 34090747
Oral Anticoagulation Therapy for Venous Thromboembolism in Norway: Time Trends and Treatment Patterns
Clin Ther, 43 (7), 1179-1190.e3
DOI 10.1016/j.clinthera.2021.04.017, PubMed 34083030
Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
Sci Rep, 11 (1), 11593
DOI 10.1038/s41598-021-90976-z, PubMed 34078971
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
PLoS Med, 18 (6), e1003599
DOI 10.1371/journal.pmed.1003599, PubMed 34061831
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
Eur Heart J Acute Cardiovasc Care, 10 (5), 570-583
DOI 10.1093/ehjacc/zuab015, PubMed 34057173
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
EuroIntervention, 17 (4), e274-e286
DOI 10.4244/EIJY21M05_01, PubMed 34057071
Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)
Front Neurol, 12, 650695
DOI 10.3389/fneur.2021.650695, PubMed 34054695
Different aspects of giving the optimal antiplatelet treatment
Eur Heart J Cardiovasc Pharmacother, 7 (3), 169-170
DOI 10.1093/ehjcvp/pvab037, PubMed 34023878
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Circulation, 143 (25), 2431-2440
DOI 10.1161/CIRCULATIONAHA.121.054698, PubMed 33993702
Effects of intermittent negative pressure treatment on circulating vascular biomarkers in patients with intermittent claudication
Vasc Med, 26 (5), 489-496
DOI 10.1177/1358863X211007933, PubMed 33985385
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
Heart, 108 (5), 345-352
DOI 10.1136/heartjnl-2020-318753, PubMed 33975877
Effect of intermittent and continuous caloric restriction on Sirtuin1 concentration depends on sex and body mass index
Nutr Metab Cardiovasc Dis, 31 (6), 1871-1878
DOI 10.1016/j.numecd.2021.03.005, PubMed 33975734
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
Open Heart, 8 (1)
DOI 10.1136/openhrt-2020-001492, PubMed 33972404
The combination of coronary sinus ostial atresia/abnormalities and a small persistent left superior vena cava-Opportunity for left ventricular lead implantation and unrecognized source of thromboembolic stroke
Heart Rhythm, 18 (7), 1064-1073
DOI 10.1016/j.hrthm.2021.05.004, PubMed 33971333
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 7 (6), 557-567
DOI 10.1093/ehjcvp/pvab038, PubMed 33956964
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation
Eur J Intern Med, 88, 21-22
DOI 10.1016/j.ejim.2021.04.008, PubMed 33934970
Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes - from single pill combinations to monitoring of a nationwide health insurance database
Blood Press, 30 (3), 143-144
DOI 10.1080/08037051.2021.1917192, PubMed 33910432
Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study
Pediatr Rheumatol Online J, 19 (1), 56
DOI 10.1186/s12969-021-00543-z, PubMed 33902632
Omega-3 supplements do not prevent cardiovascular disease
Tidsskr Nor Laegeforen, 141 (6)
DOI 10.4045/tidsskr.21.0033, PubMed 33876607
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
J Am Coll Cardiol, 77 (15), 1845-1855
DOI 10.1016/j.jacc.2021.02.049, PubMed 33858620
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
JACC Cardiovasc Interv, 14 (7), 768-780
DOI 10.1016/j.jcin.2021.02.022, PubMed 33826497
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
Ann Med, 53 (1), 485-494
DOI 10.1080/07853890.2021.1893897, PubMed 33818226
Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training
Diabetol Metab Syndr, 13 (1), 36
DOI 10.1186/s13098-021-00655-2, PubMed 33794977
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
Lancet Oncol, 22 (4), 558-570
DOI 10.1016/S1470-2045(21)00033-4, PubMed 33794209
Antiplatelet treatment in coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 7 (2), 81-82
DOI 10.1093/ehjcvp/pvab015, PubMed 33720341
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
Eur Heart J Qual Care Clin Outcomes, 8 (3), 307-314
DOI 10.1093/ehjqcco/qcaa098, PubMed 33710273
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data
Clin Res Cardiol, 110 (8), 1280-1291
DOI 10.1007/s00392-021-01822-1, PubMed 33704552
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study
Scand J Rheumatol, 50 (6), 445-454
DOI 10.1080/03009742.2021.1875040, PubMed 33650469
Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation
Scand Cardiovasc J, 55 (4), 213-219
DOI 10.1080/14017431.2021.1889653, PubMed 33650449
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 85-99
DOI 10.1093/ehjcvp/pvab018, PubMed 33638977
Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study
BMJ Open, 11 (2), e046024
DOI 10.1136/bmjopen-2020-046024, PubMed 33627355
Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis
Eur Heart J Acute Cardiovasc Care, 10 (3), 343-355
DOI 10.1093/ehjacc/zuaa025, PubMed 33620437
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries
Eur Heart J Qual Care Clin Outcomes, 8 (4), 429-436
DOI 10.1093/ehjqcco/qcab013, PubMed 33605415
Outcome in refractory out-of-hospital cardiac arrest before and after implementation of an ECPR protocol
Resuscitation, 162, 35-42
DOI 10.1016/j.resuscitation.2021.01.038, PubMed 33581226
Health-related quality of life after out-of-hospital cardiac arrest – a five-year follow-up study
Resuscitation, 162, 372-380
DOI 10.1016/j.resuscitation.2021.01.036, PubMed 33571604
Case report: a patient with thyroid storm, refractory cardiogenic shock, and cardiac arrest treated with Lugol's iodine solution and veno-arterial extra corporal membrane oxygenation support
Eur Heart J Case Rep, 5 (2), ytab017
DOI 10.1093/ehjcr/ytab017, PubMed 33569532
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
Eur Heart J Acute Cardiovasc Care, 10 (2), 224-233
DOI 10.1093/ehjacc/zuaa037, PubMed 33550362
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
J Am Coll Cardiol, 77 (4), 405-419
DOI 10.1016/j.jacc.2020.11.044, PubMed 33509397
Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
ESC Heart Fail, 8 (2), 918-927
DOI 10.1002/ehf2.13177, PubMed 33497525
Is RBBB the new LBBB? Are we going to repeat the same mistakes?
J Electrocardiol, 65, 34-36
DOI 10.1016/j.jelectrocard.2020.12.010, PubMed 33477070
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Atherosclerosis, 319, 51-61
DOI 10.1016/j.atherosclerosis.2020.12.013, PubMed 33476944
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Circulation, 143 (12), 1215-1223
DOI 10.1161/CIRCULATIONAHA.120.051020, PubMed 33461308
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
Thromb Haemost, 121 (6), 716-730
DOI 10.1055/s-0040-1721665, PubMed 33412613
Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study
Diabetes Care, 44 (3), 810-816
DOI 10.2337/dc20-1712, PubMed 33408220
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk
Blood Press, 30 (2), 90-97
DOI 10.1080/08037051.2020.1856642, PubMed 33403890
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension
Blood Press, 30 (2), 82-89
DOI 10.1080/08037051.2020.1855968, PubMed 33403886
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis
Hypertension, 77 (2), 692-705
DOI 10.1161/HYPERTENSIONAHA.120.15781, PubMed 33390044
Atrial fibrillation in registries
Eur Heart J Cardiovasc Pharmacother, 7 (1), 1-2
DOI 10.1093/ehjcvp/pvaa142, PubMed 33367509
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother, 8 (3), 227-235
DOI 10.1093/ehjcvp/pvaa140, PubMed 33367487
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Eur Heart J, 42 (6), 700-710
DOI 10.1093/eurheartj/ehaa943, PubMed 33351892
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers
Blood Press, 30 (1), 1-3
DOI 10.1080/08037051.2021.1862483, PubMed 33349063
Clinical impact of chronic substance abuse in a Norwegian ICU-population
Acta Anaesthesiol Scand, 65 (4), 515-524
DOI 10.1111/aas.13766, PubMed 33340102
The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause - aims, function and structure: Position paper of the Association for Acute CardioVascular Care of the European Society of Cardiology (AVCV), European Association of Percutaneous Coronary Interventions (EAPCI), European Heart Rhythm Association (EHRA), European Resuscitation Council (ERC), European Society for Emergency Medicine (EUSEM) and European Society of Intensive Care Medicine (ESICM)
Eur Heart J Acute Cardiovasc Care, 9 (4_suppl), S193-S202
DOI 10.1177/2048872620963492, PubMed 33327761
Music therapy as an adjunct in cardiac device lead extraction procedures: A randomized controlled trial
Appl Nurs Res, 56, 151376
DOI 10.1016/j.apnr.2020.151376, PubMed 33280783
Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long-term survivors of type 1 diabetes: A Dialong substudy
J Diabetes Investig, 12 (7), 1183-1192
DOI 10.1111/jdi.13470, PubMed 33249778
Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise
Clin Biochem, 88, 23-29
DOI 10.1016/j.clinbiochem.2020.11.005, PubMed 33245871
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
J Infect Dis, 225 (4), 661-674
DOI 10.1093/infdis/jiaa714, PubMed 33216130
Focus on blood pressure and risk factor intervention
Eur Heart J Cardiovasc Pharmacother, 6 (6), 339-340
DOI 10.1093/ehjcvp/pvaa130, PubMed 33197927
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
Circulation, 143 (6), 528-539
DOI 10.1161/CIRCULATIONAHA.120.052209, PubMed 33191772
Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis
Echocardiography, 38 (1), 31-38
DOI 10.1111/echo.14916, PubMed 33146452
Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines?
Blood Press, 29 (6), 341-343
DOI 10.1080/08037051.2020.1838766, PubMed 33140684
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis
J Cardiovasc Pharmacol, 77 (1), 87-93
DOI 10.1097/FJC.0000000000000922, PubMed 33136764
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
Eur Heart J Cardiovasc Pharmacother, 7 (5), 453-459
DOI 10.1093/ehjcvp/pvaa126, PubMed 33135079
Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
PLoS One, 15 (10), e0241333
DOI 10.1371/journal.pone.0241333, PubMed 33119664
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes
J Pharm Sci, 110 (1), 432-437
DOI 10.1016/j.xphs.2020.10.027, PubMed 33091408
Cardiac Dimensions and Function Are Not Altered among Females with the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Healthcare (Basel), 8 (4)
DOI 10.3390/healthcare8040406, PubMed 33081294
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
Eur Heart J, 41 (44), 4245-4255
DOI 10.1093/eurheartj/ehaa649, PubMed 33051646
The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up
Blood Press, 30 (1), 41-50
DOI 10.1080/08037051.2020.1828818, PubMed 33030064
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime
J Hypertens, 38 (11), 2144-2145
DOI 10.1097/HJH.0000000000002671, PubMed 33027108
Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects
Nutrients, 12 (10)
DOI 10.3390/nu12103014, PubMed 33008057
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
Curr Heart Fail Rep, 17 (6), 397-408
DOI 10.1007/s11897-020-00486-8, PubMed 32979150
Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe
Scand Cardiovasc J, 54 (6), 358-360
DOI 10.1080/14017431.2020.1820563, PubMed 32945201
The perils of data sharing, meta-analyses, and estimating cardiovascular risk
Eur Heart J Cardiovasc Pharmacother, 7 (3), e55-e57
DOI 10.1093/ehjcvp/pvaa109, PubMed 32941601
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
Eur Heart J Cardiovasc Pharmacother, 8 (2), 187-210
DOI 10.1093/ehjcvp/pvaa108, PubMed 32941594
Minimizing bleeding events
Eur Heart J Cardiovasc Pharmacother, 6 (5), 271-272
DOI 10.1093/ehjcvp/pvaa100, PubMed 32932523
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
EBioMedicine, 60, 102985
DOI 10.1016/j.ebiom.2020.102985, PubMed 32927275
[Ten-year prediction of cardiovascular disease in healthy Norwegian men, based on NORRISK-2]
Tidsskr Nor Laegeforen, 140 (12)
DOI 10.4045/tidsskr.20.0089, PubMed 32900157
Cardioversion Safety - Are We Doing Enough?
Cardiology, 145 (11), 740-745
DOI 10.1159/000509343, PubMed 32898849
Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease
Thromb Res, 196, 106-108
DOI 10.1016/j.thromres.2020.08.023, PubMed 32853976
Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men
Sci Rep, 10 (1), 14055
DOI 10.1038/s41598-020-71109-4, PubMed 32820223
[Complications and mortality among patients hospitalised with COVID-19]
Tidsskr Nor Laegeforen, 140 (11)
DOI 10.4045/tidsskr.20.0432, PubMed 32815354
The cancer patient and cardiology
Eur J Heart Fail, 22 (12), 2290-2309
DOI 10.1002/ejhf.1985, PubMed 32809231
The International Society of Hypertension Guidelines 2020 - a new drug treatment recommendation in the wrong direction?
Blood Press, 29 (5), 264-266
DOI 10.1080/08037051.2020.1806494, PubMed 32808555
β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry
Biomed Hub, 5 (1), 9-18
DOI 10.1159/000505474, PubMed 32775329
Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study
Open Heart, 7 (2)
DOI 10.1136/openhrt-2020-001296, PubMed 32719074
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Card Fail Rev, 6, e19
DOI 10.15420/cfr.2020.03, PubMed 32714567
Incidence and prevalence of venous thromboembolism in Norway 2010-2017
Thromb Res, 195, 165-168
DOI 10.1016/j.thromres.2020.07.011, PubMed 32707359
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
Future Cardiol, 17 (1), 19-38
DOI 10.2217/fca-2020-0014, PubMed 32696663
Left ventricular dysfunction in COPD without pulmonary hypertension
PLoS One, 15 (7), e0235075
DOI 10.1371/journal.pone.0235075, PubMed 32673327
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?
Cardiovasc Drugs Ther, 34 (6), 865-870
DOI 10.1007/s10557-020-07039-0, PubMed 32671603
Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?
Eur Heart J Cardiovasc Pharmacother, 6 (4), 201-202
DOI 10.1093/ehjcvp/pvaa075, PubMed 32668002
Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients
Stroke, 51 (8), 2411-2417
DOI 10.1161/STROKEAHA.119.028523, PubMed 32640944
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
J Cardiovasc Pharmacol, 76 (1), 4-22
DOI 10.1097/FJC.0000000000000859, PubMed 32639325
Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?
J Hypertens, 38 (8), 1396-1406
DOI 10.1097/HJH.0000000000002532, PubMed 32618895
Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
Clin Epidemiol, 12, 595-605
DOI 10.2147/CLEP.S249785, PubMed 32606985
Intensification of antithrombotic therapy for chronic atherosclerosis
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0066, PubMed 32602309
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Ann Noninvasive Electrocardiol, 25 (6), e12784
DOI 10.1111/anec.12784, PubMed 32592427
On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy
Blood Press, 29 (5), 319-326
DOI 10.1080/08037051.2020.1782171, PubMed 32586143
Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial?
Blood Press, 29 (4), 199-201
DOI 10.1080/08037051.2020.1782595, PubMed 32584173
Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis
Neurology, 95 (2), e121-e130
DOI 10.1212/WNL.0000000000009756, PubMed 32554767
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Circulation, 142 (7), 621-642
DOI 10.1161/CIRCULATIONAHA.120.046361, PubMed 32546049
Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016
ESC Heart Fail, 7 (4), 1917-1926
DOI 10.1002/ehf2.12773, PubMed 32530563
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project
J Hypertens (in press) (Retracted)
DOI 10.1097/HJH.0000000000002479, PubMed 32516290
Adherence to guidelines, compliance to treatment, and treatment quality
Eur Heart J Cardiovasc Pharmacother, 4 (4), 189-190
DOI 10.1093/ehjcvp/pvy033, PubMed 32420591
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
J Clin Lipidol, 14 (3), 339-345
DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822
Focus on subpopulations of atrial fibrillation patients
Eur Heart J Cardiovasc Pharmacother, 6 (3), 131-132
DOI 10.1093/ehjcvp/pvaa034, PubMed 32412082
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Eur Heart J, 41 (19), 1839-1851
DOI 10.1093/eurheartj/ehaa381, PubMed 32405641
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
EuroIntervention, 16 (3), 233-246
DOI 10.4244/EIJY20M05_01, PubMed 32404302
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size
Eur Heart J Acute Cardiovasc Care, 9 (4), 302-312
DOI 10.1177/2048872620923641, PubMed 32403934
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
PLoS One, 15 (5), e0233174
DOI 10.1371/journal.pone.0233174, PubMed 32401813
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project
Blood Press, 29 (3), 135-136
DOI 10.1080/08037051.2020.1747696, PubMed 32338542
Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers
Hypertension, 75 (6), 1584-1592
DOI 10.1161/HYPERTENSIONAHA.119.14443, PubMed 32336236
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Heart Fail Rev, 26 (6), 1421-1435
DOI 10.1007/s10741-020-09954-8, PubMed 32314085
Annexin V+ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
J Diabetes Res, 2020, 7216863
DOI 10.1155/2020/7216863, PubMed 32309448
Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease
Mediators Inflamm, 2020, 5080743
DOI 10.1155/2020/5080743, PubMed 32308555
Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men
Stroke, 51 (5), 1435-1441
DOI 10.1161/STROKEAHA.119.027233, PubMed 32268850
Facilitators of and barriers to reducing thirty-day readmissions and improving patient-reported outcomes after surgical aortic valve replacement: a process evaluation of the AVRre trial
BMC Health Serv Res, 20 (1), 256
DOI 10.1186/s12913-020-05125-5, PubMed 32220252
Rosuvastatin alters the genetic composition of the human gut microbiome
Sci Rep, 10 (1), 5397
DOI 10.1038/s41598-020-62261-y, PubMed 32214138
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Eur Heart J, 41 (16), 1588-1599
DOI 10.1093/eurheartj/ehaa121, PubMed 32211888
Eivind Berge, MD, PhD, 1964-2020: Cardiologist Who Was Fighting Stroke
Stroke, 51 (5), 1353-1355
DOI 10.1161/STROKEAHA.120.029351, PubMed 32200755
Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
Sci Rep, 10 (1), 5007
DOI 10.1038/s41598-020-61971-7, PubMed 32193509
Pharmacy-dispensed drugs for secondary prevention after myocardial infarction
Tidsskr Nor Laegeforen, 140 (4)
DOI 10.4045/tidsskr.19.0416, PubMed 32192264
Lipids and antithrombotic treatment
Eur Heart J Cardiovasc Pharmacother, 6 (2), 71
DOI 10.1093/ehjcvp/pvaa014, PubMed 32176294
Incidence, risk factors and outcome of young patients with myocardial infarction
Heart, 106 (18), 1420-1426
DOI 10.1136/heartjnl-2019-316067, PubMed 32111640
Duration of Elevated Heart Rate Is an Important Predictor of Exercise-Induced Troponin Elevation
J Am Heart Assoc, 9 (4), e014408
DOI 10.1161/JAHA.119.014408, PubMed 32065043
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
EBioMedicine, 52, 102649
DOI 10.1016/j.ebiom.2020.102649, PubMed 32062353
How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers
Blood Press, 29 (2), 68-69
DOI 10.1080/08037051.2020.1726101, PubMed 32049554
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur Heart J Cardiovasc Pharmacother, 7 (2), 125-140
DOI 10.1093/ehjcvp/pvaa009, PubMed 32049278
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study
Cerebrovasc Dis Extra, 10 (1), 11-20
DOI 10.1159/000504529, PubMed 32028277
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
J Am Heart Assoc, 9 (3), e013518
DOI 10.1161/JAHA.119.013518, PubMed 32000579
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Eur Stroke J, 4 (3), 198-223
DOI 10.1177/2396987319841187, PubMed 31984228
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
ESC Heart Fail, 7 (2), 456-466
DOI 10.1002/ehf2.12596, PubMed 31978943
Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
Eur Heart J Acute Cardiovasc Care, 9 (4), 348-357
DOI 10.1177/2048872619894255, PubMed 31976747
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
Eur Heart J Acute Cardiovasc Care, 9 (1), 76-89
DOI 10.1177/2048872619885346, PubMed 31958018
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
J Am Coll Cardiol, 75 (2), 133-144
DOI 10.1016/j.jacc.2019.10.057, PubMed 31948641
Procoagulant activity in children and adolescents on intensive insulin therapy
Pediatr Diabetes, 21 (3), 496-504
DOI 10.1111/pedi.12978, PubMed 31943582
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
Eur Heart J Cardiovasc Pharmacother, 6 (2), 75-85
DOI 10.1093/ehjcvp/pvz086, PubMed 31942972
Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-Respiratory Arrest Study (NORCAST)
Resuscitation, 149, 170-179
DOI 10.1016/j.resuscitation.2019.12.031, PubMed 31926258
Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study
J Med Internet Res, 22 (1), e15445
DOI 10.2196/15445, PubMed 31909717
Focus on pharma in acute coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 6 (1), 1-2
DOI 10.1093/ehjcvp/pvz074, PubMed 31909430
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension
Blood Press, 29 (1), 1-2
DOI 10.1080/08037051.2020.1707440, PubMed 31902246
Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study
Clin Biochem, 78, 10-17
DOI 10.1016/j.clinbiochem.2019.12.016, PubMed 31899280
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Am Heart J, 221, 1-8
DOI 10.1016/j.ahj.2019.10.013, PubMed 31896036
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
Diabetol Metab Syndr, 11, 109
DOI 10.1186/s13098-019-0508-9, PubMed 31890043
Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke
Neurology, 94 (5), e439-e452
DOI 10.1212/WNL.0000000000008881, PubMed 31882527
Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
BMC Geriatr, 19 (1), 376
DOI 10.1186/s12877-019-1383-9, PubMed 31881852
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
Atherosclerosis, 296, 74-82
DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625
Quality of life and psychological outcomes of body-weight supported locomotor training in spinal cord injured persons with long-standing incomplete lesions
Spinal Cord, 58 (5), 560-569
DOI 10.1038/s41393-019-0401-2, PubMed 31848443
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
J Am Coll Cardiol, 74 (23), 2893-2904
DOI 10.1016/j.jacc.2019.09.059, PubMed 31806133
Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
Rejuvenation Res, 23 (4), 324-332
DOI 10.1089/rej.2019.2258, PubMed 31805818
Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model
Intensive Care Med Exp, 7 (1), 65
DOI 10.1186/s40635-019-0279-5, PubMed 31802327
Medical Therapies for Heart Failure With Preserved Ejection Fraction
Hypertension, 75 (1), 23-32
DOI 10.1161/HYPERTENSIONAHA.119.14057, PubMed 31786973
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
Mediators Inflamm, 2019, 7816491
DOI 10.1155/2019/7816491, PubMed 31772506
Assessing hypertension therapies: randomization or confounding by indication?
Nat Rev Cardiol, 17 (2), 73-74
DOI 10.1038/s41569-019-0313-z, PubMed 31768007
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
Europace, 22 (2), 195-204
DOI 10.1093/europace/euz292, PubMed 31747004
Functional and Structural Adaptations of Skeletal Muscle in Long-Term Juvenile Dermatomyositis: A Controlled Cross-Sectional Study
Arthritis Rheumatol, 72 (5), 837-848
DOI 10.1002/art.41174, PubMed 31746550
Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease
Rheumatology (Oxford), 59 (8), 1862-1870
DOI 10.1093/rheumatology/kez531, PubMed 31740970
Exercise Systolic Blood Pressure at Moderate Workload Is Linearly Associated With Coronary Disease Risk in Healthy Men
Hypertension, 75 (1), 44-50
DOI 10.1161/HYPERTENSIONAHA.119.13528, PubMed 31735088
Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants
Neurology, 93 (24), e2170-e2180
DOI 10.1212/WNL.0000000000008615, PubMed 31719135
Experiences of informal caregivers after cardiac surgery: a systematic integrated review of qualitative and quantitative studies
BMJ Open, 9 (11), e032751
DOI 10.1136/bmjopen-2019-032751, PubMed 31719093
Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
Blood Press, 29 (2), 123-134
DOI 10.1080/08037051.2019.1684817, PubMed 31718316
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS
Am Heart J, 218, 57-65
DOI 10.1016/j.ahj.2019.08.016, PubMed 31707329
Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
Cardiology, 144 (3-4), 79-89
DOI 10.1159/000503442, PubMed 31689705
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
J Clin Med, 8 (11)
DOI 10.3390/jcm8111834, PubMed 31683969
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
BMC Med, 17 (1), 198
DOI 10.1186/s12916-019-1428-0, PubMed 31679516
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Open Heart, 6 (2), e001108
DOI 10.1136/openhrt-2019-001108, PubMed 31673391
Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes
Blood Press, 28 (6), 356-357
DOI 10.1080/08037051.2019.1678261, PubMed 31623467
Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium
Eur J Prev Cardiol, 27 (3), 234-243
DOI 10.1177/2047487319877078, PubMed 31619084
Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
BMC Cardiovasc Disord, 19 (1), 221
DOI 10.1186/s12872-019-1205-1, PubMed 31615411
Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH
Eur Heart J, 41 (16), 1572-1574
DOI 10.1093/eurheartj/ehz703, PubMed 31580419
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Circulation, 140 (23), 1921-1932
DOI 10.1161/CIRCULATIONAHA.119.043308, PubMed 31557056
The PARAGON-Heart failure trial - another disappointment for heart failure patients with hypertension and preserved ejection fraction
Blood Press, 28 (5), 276-278
DOI 10.1080/08037051.2019.1664717, PubMed 31542958
European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723
Eur Heart J Cardiovasc Pharmacother, 5 (4), 183-184
DOI 10.1093/ehjcvp/pvz041, PubMed 31531677
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Eur Heart J, 41 (3), 407-477
DOI 10.1093/eurheartj/ehz425, PubMed 31504439
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?
Am J Med, 133 (3), 347-351
DOI 10.1016/j.amjmed.2019.07.046, PubMed 31442391
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon
Cardiovasc Drugs Ther, 33 (5), 589-597
DOI 10.1007/s10557-019-06901-0, PubMed 31418141
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 6 (2), 104-114
DOI 10.1093/ehjcvp/pvz033, PubMed 31397840
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Eur Heart J Cardiovasc Pharmacother, 6 (2), 86-93
DOI 10.1093/ehjcvp/pvz036, PubMed 31392312
Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates following aortic valve replacement -A randomized controlled trial
Int J Cardiol, 300, 66-72
DOI 10.1016/j.ijcard.2019.07.087, PubMed 31387822
Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation
Catheter Cardiovasc Interv, 95 (6), 1171-1175
DOI 10.1002/ccd.28419, PubMed 31379116
Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials
Heart Fail Rev, 25 (2), 161-171
DOI 10.1007/s10741-019-09832-y, PubMed 31364027
The myth of 'stable' coronary artery disease
Nat Rev Cardiol, 17 (1), 9-21
DOI 10.1038/s41569-019-0233-y, PubMed 31358978
Challenging Anticoagulation in Advanced Renal Failure
Am J Med, 132 (11), 1258-1259
DOI 10.1016/j.amjmed.2019.07.002, PubMed 31356767
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
PLoS One, 14 (7), e0220079
DOI 10.1371/journal.pone.0220079, PubMed 31335881
Are People With Masked Hypertension Adherent to Their Antihypertensive Medication?
Hypertension, 74 (3), 497-498
DOI 10.1161/HYPERTENSIONAHA.119.13350, PubMed 31327260
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox
Clin Cardiol, 42 (10), 1028-1040
DOI 10.1002/clc.23232, PubMed 31317575
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF
Am J Med, 132 (12), 1431-1440.e7
DOI 10.1016/j.amjmed.2019.06.008, PubMed 31306621
Heat Stress Impacts on Cardiac Mortality in Nepali Migrant Workers in Qatar
Cardiology, 143 (1), 37-48
DOI 10.1159/000500853, PubMed 31302648
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
Eur Heart J Cardiovasc Pharmacother, 6 (2), 97-103
DOI 10.1093/ehjcvp/pvz029, PubMed 31298686
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Am Heart J, 215, 83-90
DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604
Mediastinitis in open heart surgery: a systematic review and meta-analysis of risk factors
Scand Cardiovasc J, 53 (5), 226-234
DOI 10.1080/14017431.2019.1642508, PubMed 31290699
Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients - data from the CHILL-MI, MITOCARE and SOCCER trials
BMC Cardiovasc Disord, 19 (1), 161
DOI 10.1186/s12872-019-1139-7, PubMed 31269907
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design
Eur Stroke J, 4 (2), 172-180
DOI 10.1177/2396987319837089, PubMed 31259265
Associations between change in blood pressure and functional outcome, early events and death: results from the Efficacy of Nitric Oxide in Stroke trial
J Hypertens, 37 (10), 2104-2109
DOI 10.1097/HJH.0000000000002154, PubMed 31246895
The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload
Sci Rep, 9 (1), 9206
DOI 10.1038/s41598-019-45651-9, PubMed 31235849
Antiplatelet treatment in acute coronary syndrome. Still an issue
Eur Heart J Cardiovasc Pharmacother, 5 (3), 125-126
DOI 10.1093/ehjcvp/pvz018, PubMed 31210265
A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease
Thromb J, 17, 11
DOI 10.1186/s12959-019-0197-5, PubMed 31198410
Long-term cardiovascular morbidity following hyperemesis gravidarum: A Norwegian nationwide cohort study
PLoS One, 14 (6), e0218051
DOI 10.1371/journal.pone.0218051, PubMed 31188868
The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction
Blood Press, 28 (4), 215-216
DOI 10.1080/08037051.2019.1625523, PubMed 31184508
Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage
J Stroke Cerebrovasc Dis, 28 (8), 2262-2267
DOI 10.1016/j.jstrokecerebrovasdis.2019.05.010, PubMed 31178359
Mechanical dispersion as a marker of left ventricular dysfunction and prognosis in stable coronary artery disease
Int J Cardiovasc Imaging, 35 (7), 1265-1275
DOI 10.1007/s10554-019-01583-z, PubMed 31165941
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome
Eur J Prev Cardiol, 26 (16), 1751-1759
DOI 10.1177/2047487319852809, PubMed 31154828
Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis
Heart, 105 (21), 1629-1633
DOI 10.1136/heartjnl-2018-314462, PubMed 31154431
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther, 26 (6), e671-e678
DOI 10.1097/MJT.0000000000000883, PubMed 31145139
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Eur Heart J Cardiovasc Pharmacother, 5 (3), 171-180
DOI 10.1093/ehjcvp/pvz016, PubMed 31119266
A study of atherothrombotic biomarkers in welders
Int Arch Occup Environ Health, 92 (7), 1023-1031
DOI 10.1007/s00420-019-01441-4, PubMed 31114965
High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
Nutrients, 11 (5)
DOI 10.3390/nu11051114, PubMed 31109111
Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
Atherosclerosis, 286, 53-59
DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620
"Doctor, Should I Keep Taking an Aspirin a Day?"
N Engl J Med, 380 (20), 1967-1970
DOI 10.1056/NEJMclde1903004, PubMed 31091380
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited
Blood Press, 28 (3), 144-145
DOI 10.1080/08037051.2019.1614278, PubMed 31076016
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries
Clin Chem, 65 (8), 1023-1030
DOI 10.1373/clinchem.2018.301085, PubMed 31072836
Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
ESC Heart Fail, 6 (3), 557-558
DOI 10.1002/ehf2.12437, PubMed 31034162
Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
Diab Vasc Dis Res, 16 (5), 431-439
DOI 10.1177/1479164119843094, PubMed 31023084
High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease
Int J Cardiol, 287, 1-6
DOI 10.1016/j.ijcard.2019.04.019, PubMed 31006595
ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries
Int J Cardiol, 287, 128-131
DOI 10.1016/j.ijcard.2019.04.028, PubMed 31003795
IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
PLoS One, 14 (4), e0215640
DOI 10.1371/journal.pone.0215640, PubMed 31002684
Take a Blood Pressure Pill or Benefit from Renal Denervation?
Eur Heart J, 39 (33), 3010-3012
DOI 10.1093/eurheartj/ehy440, PubMed 30990870
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
Circulation, 140 (1), 31-41
DOI 10.1161/CIRCULATIONAHA.118.037934, PubMed 30987448
Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction
Eur J Prev Cardiol, 26 (13), 1373-1382
DOI 10.1177/2047487319841940, PubMed 30966816
Sex Differences in Quality of Life in Patients With Atrial Fibrillation: A Systematic Review
J Am Heart Assoc, 8 (8), e010992
DOI 10.1161/JAHA.118.010992, PubMed 30957624
Future of Renal Sympathetic Denervation in the Treatment of Hypertension
J Am Coll Cardiol, 73 (13), 1643-1645
DOI 10.1016/j.jacc.2019.02.008, PubMed 30947916
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease
BMC Med, 17 (1), 72
DOI 10.1186/s12916-019-1306-9, PubMed 30943979
Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
Diab Vasc Dis Res, 16 (4), 360-368
DOI 10.1177/1479164119836922, PubMed 30939905
Late Pseudoaneurysm After Access Site Closure with Manta in Transfemoral Aortic Valve Implantation
EJVES Short Rep, 42, 34-36
DOI 10.1016/j.ejvssr.2018.10.003, PubMed 30931405
Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease
BMC Cardiovasc Disord, 19 (1), 71
DOI 10.1186/s12872-019-1062-y, PubMed 30922234
[Heart failure with preserved ejection fraction]
Tidsskr Nor Laegeforen, 139 (6)
DOI 10.4045/tidsskr.18.0523, PubMed 30917641
The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
Thromb Res, 177, 154-156
DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
The Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial
Int J Geriatr Psychiatry, 34 (7), 974-981
DOI 10.1002/gps.5098, PubMed 30901487
Robot-assisted locomotor training did not improve walking function in patients with chronic incomplete spinal cord injury: A randomized clinical trial
J Rehabil Med, 51 (5), 385-389
DOI 10.2340/16501977-2547, PubMed 30895326
Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study
J Rheumatol, 46 (7), 739-747
DOI 10.3899/jrheum.180526, PubMed 30877222
European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
Eur Heart J Cardiovasc Pharmacother, 5 (2), 59
DOI 10.1093/ehjcvp/pvz009, PubMed 30874813
Unsolved issues in oral anticoagulation treatment in atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 5 (2), 60-61
DOI 10.1093/ehjcvp/pvz008, PubMed 30874812
Editor's Note
Cardiology, 142 (1), 1
DOI 10.1159/000497089, PubMed 30852568
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
J Diabetes Complications, 33 (5), 383-389
DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
Eur Heart J Suppl, 21 (Suppl A), A28-A33
DOI 10.1093/eurheartj/suy035, PubMed 30837802
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Int J Cardiol, 289, 83-90
DOI 10.1016/j.ijcard.2019.01.109, PubMed 30827731
Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implement
Pol Arch Intern Med, 129 (2), 78-79
DOI 10.20452/pamw.4467, PubMed 30816102
Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
Blood Press, 28 (2), 75-76
DOI 10.1080/08037051.2019.1584975, PubMed 30806086
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
Heart, 105 (16), 1252-1259
DOI 10.1136/heartjnl-2018-314256, PubMed 30792238
Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
Catheter Cardiovasc Interv, 94 (5), 660-668
DOI 10.1002/ccd.28157, PubMed 30790446
Contemporary practice of CRT implantation in scandinavia compared to Europe
Scand Cardiovasc J, 53 (1), 9-13
DOI 10.1080/14017431.2019.1583364, PubMed 30761919
On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
Eur Heart J, 40 (19), 1501-1503
DOI 10.1093/eurheartj/ehz014, PubMed 30753396
Medical Misinformation: Vet the Message!
J Cardiovasc Pharmacol, 73 (2), 61-62
DOI 10.1097/FJC.0000000000000648, PubMed 30730472
Health Care Professionals' Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey
J Med Internet Res, 21 (2), e10362
DOI 10.2196/10362, PubMed 30724744
New data on antihypertensive drugs and risk of cancer: should we worry?
Blood Press, 28 (1), 1-3
DOI 10.1080/08037051.2019.1568182, PubMed 30714837
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
Aging Cell, 18 (2), e12897
DOI 10.1111/acel.12897, PubMed 30712319
Medical misinformation: Vet the message!
Heart Rhythm, 16 (3), 332-333
DOI 10.1016/j.hrthm.2018.12.030, PubMed 30703343
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
DOI 10.1093/ehjcvp/pvz005, PubMed 30698668
Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study
Blood Press, 28 (2), 84-92
DOI 10.1080/08037051.2019.1569463, PubMed 30698038
Medical misinformation: vet the message!
Eur Heart J Qual Care Clin Outcomes, 5 (2), 83-84
DOI 10.1093/ehjqcco/qcy057, PubMed 30689789
Medical misinformation: vet the message!
Eur Heart J Cardiovasc Pharmacother, 5 (2), 62-63
DOI 10.1093/ehjcvp/pvz001, PubMed 30689786
Medical misinformation: vet the message!
Cardiovasc Res, 115 (14), e187-e188
DOI 10.1093/cvr/cvz007, PubMed 30689762
Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
Exp Gerontol, 119, 53-60
DOI 10.1016/j.exger.2019.01.020, PubMed 30684534
Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide
CVIR Endovasc, 1 (1), 20
DOI 10.1186/s42155-018-0026-0, PubMed 30652151
Trifecta has lower gradient and less prosthesis-patient mismatch than Mosaic Ultra in the aortic position: A prospective randomized study
J Thorac Cardiovasc Surg, 158 (4), 1032-1039
DOI 10.1016/j.jtcvs.2018.11.020, PubMed 30635187
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard?
J Hypertens, 37 (6), 1148-1153
DOI 10.1097/HJH.0000000000002021, PubMed 30624370
Old and new drugs in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (1), 1-2
DOI 10.1093/ehjcvp/pvy046, PubMed 30615170
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
Blood Press, 28 (2), 77-83
DOI 10.1080/08037051.2018.1524707, PubMed 30614275
New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Open Heart, 5 (2), e000931
DOI 10.1136/openhrt-2018-000931, PubMed 30613418
Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
BMC Cardiovasc Disord, 19 (1), 4
DOI 10.1186/s12872-018-0989-8, PubMed 30611196
Change in Cardiorespiratory Fitness and Risk of Stroke and Death: Long-Term Follow-Up of Healthy Middle-Aged Men
Stroke, 50 (1), 155-161
DOI 10.1161/STROKEAHA.118.021798, PubMed 30580727
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
Am Heart J, 208, 123-131
DOI 10.1016/j.ahj.2018.09.017, PubMed 30579505
Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study
BJGP Open, 2 (3), bjgpopen18X101596
DOI 10.3399/bjgpopen18X101596, PubMed 30564729
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
J Cardiovasc Pharmacol Ther, 24 (3), 215-224
DOI 10.1177/1074248418812167, PubMed 30563349
Increases in Circulating Cardiac Troponin Are Not Always Associated with Myocardial Cell Death
Clin Lab, 64 (11)
DOI 10.7754/Clin.Lab.2018.180615, PubMed 30549980
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
Am Heart J, 208, 37-46
DOI 10.1016/j.ahj.2018.10.005, PubMed 30530121
Cardiorespiratory fitness in long-term juvenile dermatomyositis: a controlled, cross-sectional study of active/inactive disease
Rheumatology (Oxford), 58 (3), 492-501
DOI 10.1093/rheumatology/key342, PubMed 30508195
Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
Am J Med, 132 (3), 374-381.e1
DOI 10.1016/j.amjmed.2018.11.010, PubMed 30503881
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
J Hypertens, 37 (1), 16-23
DOI 10.1097/HJH.0000000000001994, PubMed 30499920
Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results
J Hypertens, 37 (1), 6-8
DOI 10.1097/HJH.0000000000001874, PubMed 30499916
Response to letters from Torp-Pedersen and colleagues and de Courson and colleagues
Eur Heart J, 39 (47), 4221
DOI 10.1093/eurheartj/ehy605, PubMed 30496492
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
Open Heart, 5 (2), e000908
DOI 10.1136/openhrt-2018-000908, PubMed 30487982
Manually assisted body-weight supported locomotor training does not re-establish walking in non-walking subjects with chronic incomplete spinal cord injury: A randomized clinical trial
J Rehabil Med, 51 (2), 113-119
DOI 10.2340/16501977-2508, PubMed 30483724
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Cardiovasc Res, 115 (2), 266-276
DOI 10.1093/cvr/cvy295, PubMed 30475996
Exercise capacity in COPD patients with exercise-induced pulmonary hypertension
Int J Chron Obstruct Pulmon Dis, 13, 3599-3610
DOI 10.2147/COPD.S161175, PubMed 30464443
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure
Int J Cardiol, 277, 166-172
DOI 10.1016/j.ijcard.2018.10.079, PubMed 30416028
MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
PLoS One, 13 (11), e0206723
DOI 10.1371/journal.pone.0206723, PubMed 30412607
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T
J Am Coll Cardiol, 72 (19), 2309-2320
DOI 10.1016/j.jacc.2018.08.2165, PubMed 30384887
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
Blood Press, 27 (6), 314-340
DOI 10.1080/08037051.2018.1527177, PubMed 30380928
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension
Blood Press, 27 (6), 313
DOI 10.1080/08037051.2018.1530564, PubMed 30380927
Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke
Cochrane Database Syst Rev, 10 (10), CD009292
DOI 10.1002/14651858.CD009292.pub2, PubMed 30365156
Preserved endothelial function in young adults with type 1 diabetes
PLoS One, 13 (10), e0206523
DOI 10.1371/journal.pone.0206523, PubMed 30359432
Optimal Blood Pressure Target in Diabetic and Nondiabetic Hypertensive Patients
Circ Res, 123 (5), 528-530
DOI 10.1161/CIRCRESAHA.118.312763, PubMed 30355140
Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
Cardiovasc Res, 115 (4), 752-764
DOI 10.1093/cvr/cvy257, PubMed 30351410
Myocardial fibrosis
Tidsskr Nor Laegeforen, 138 (16)
DOI 10.4045/tidsskr.17.1027, PubMed 30344312
SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up
J Hypertens, 37 (5), 949-955
DOI 10.1097/HJH.0000000000001959, PubMed 30325341
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Liver Int, 39 (2), 371-381
DOI 10.1111/liv.13979, PubMed 30269440
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
Front Immunol, 9, 2035
DOI 10.3389/fimmu.2018.02035, PubMed 30258440
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
Eur Heart J Cardiovasc Pharmacother, 5 (1), 47-54
DOI 10.1093/ehjcvp/pvy038, PubMed 30247574
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
Heart, 105 (3), 235-242
DOI 10.1136/heartjnl-2018-313351, PubMed 30209126
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
Eur Heart J Cardiovasc Pharmacother, 5 (4), 210-215
DOI 10.1093/ehjcvp/pvy035, PubMed 30192939
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
Eur Heart J Cardiovasc Pharmacother, 5 (1), 12-20
DOI 10.1093/ehjcvp/pvy034, PubMed 30192930
[Not Available]
Tidsskr Nor Laegeforen, 138 (13)
DOI 10.4045/tidsskr.18.0627, PubMed 30180491
Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study
Blood Press, 27 (5), 247-248
DOI 10.1080/08037051.2018.1507621, PubMed 30175661
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995
Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study
Blood Press, 27 (6), 368-375
DOI 10.1080/08037051.2018.1505425, PubMed 30129785
Recanalisation therapies for wake-up stroke
Cochrane Database Syst Rev, 8 (8), CD010995
DOI 10.1002/14651858.CD010995.pub2, PubMed 30129656
Critical appraisal of the COMPASS trial
Eur Heart J Cardiovasc Pharmacother, 4 (4), 191-192
DOI 10.1093/ehjcvp/pvy027, PubMed 30113628
Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men
Eur J Prev Cardiol, 25 (15), 1655-1663
DOI 10.1177/2047487318793459, PubMed 30103630
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Eur Heart J Cardiovasc Pharmacother, 4 (4), 230-236
DOI 10.1093/ehjcvp/pvy028, PubMed 30099530
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study
Cardiology, 140 (3), 178-185
DOI 10.1159/000491745, PubMed 30099440
Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study
Clin Cardiol, 41 (10), 1322-1327
DOI 10.1002/clc.23043, PubMed 30098028
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study
Cardiology, 140 (3), 152-154
DOI 10.1159/000490656, PubMed 30089282
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
ESC Heart Fail, 5 (5), 977-984
DOI 10.1002/ehf2.12332, PubMed 30088346
Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
BMC Cardiovasc Disord, 18 (1), 160
DOI 10.1186/s12872-018-0896-z, PubMed 30075751
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Europace, 21 (2), 192-193
DOI 10.1093/europace/euy174, PubMed 30052888
New input on antiplatelet treatment and registry studies
Eur Heart J Cardiovasc Pharmacother, 4 (3), 129-130
DOI 10.1093/ehjcvp/pvy016, PubMed 30052852
Peripheral arterial disease and limb salvage: a new arena for the cardiologist
Eur Heart J Cardiovasc Pharmacother, 4 (3), 136-137
DOI 10.1093/ehjcvp/pvy014, PubMed 30052851
Author's response to: letter to the editor
Heart Fail Rev, 23 (5), 819
DOI 10.1007/s10741-018-9728-6, PubMed 30043131
Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
Diabetol Metab Syndr, 10, 59
DOI 10.1186/s13098-018-0360-3, PubMed 30038669
The burden of heart failure in the general population: a clearer and more concerning picture
J Thorac Dis, 10 (Suppl 17), S1934-S1937
DOI 10.21037/jtd.2018.04.153, PubMed 30023084
Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men
BMC Pulm Med, 18 (1), 118
DOI 10.1186/s12890-018-0655-z, PubMed 30021542
Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis
Epilepsy Behav, 86, 193-199
DOI 10.1016/j.yebeh.2018.06.037, PubMed 30017838
Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
DOI 10.1152/ajpheart.00208.2018, PubMed 30004809
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (4), 563-568
DOI 10.1016/j.jelectrocard.2018.03.016, PubMed 29996989
Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
Eur Radiol, 29 (2), 941-950
DOI 10.1007/s00330-018-5588-7, PubMed 29980929
Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
J Am Coll Cardiol, 72 (2), 187-198
DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293
Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
Diab Vasc Dis Res, 15 (5), 458-464
DOI 10.1177/1479164118785307, PubMed 29972041
The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging
Ann Noninvasive Electrocardiol, 23 (6), e12580
DOI 10.1111/anec.12580, PubMed 29971868
Response to the editor
Heart Fail Rev (in press)
DOI 10.1007/s10741-018-9723-y, PubMed 29968222
Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure
Blood Press, 27 (4), 185-187
DOI 10.1080/08037051.2018.1486178, PubMed 29936868
High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis
Scand J Clin Lab Invest, 78 (5), 386-392
DOI 10.1080/00365513.2018.1481224, PubMed 29933716
The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses
BMC Pharmacol Toxicol, 19 (1), 29
DOI 10.1186/s40360-018-0218-1, PubMed 29884231
A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice
Cardiovasc Res, 114 (12), 1680-1690
DOI 10.1093/cvr/cvy141, PubMed 29878127
Cardiovascular risk profile at the age of 40-45 in women with previous hyperemesis gravidarum or hypertensive disorders in pregnancy: A population-based study
Pregnancy Hypertens, 12, 129-135
DOI 10.1016/j.preghy.2018.04.013, PubMed 29858105
Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Int J Cardiol, 268, 187-192
DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279
Take a blood pressure pill or undergo renal denervation?
Lancet, 391 (10137), 2298-2300
DOI 10.1016/S0140-6736(18)31126-7, PubMed 29803587
Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
Int J Cardiol, 268, 85-91
DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 4 (3), 180-188
DOI 10.1093/ehjcvp/pvy015, PubMed 29726985
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
Sci Rep, 8 (1), 6725
DOI 10.1038/s41598-018-25168-3, PubMed 29712976
What is not to like about large national or international registries and databases?
Int J Cardiol, 262, 117-118
DOI 10.1016/j.ijcard.2018.03.062, PubMed 29706389
Longitudinal left ventricular function is globally depressed within a week of STEMI
Clin Physiol Funct Imaging, 38 (6), 1029-1037
DOI 10.1111/cpf.12521, PubMed 29701310
Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
Clin Appl Thromb Hemost, 24 (7), 1088-1094
DOI 10.1177/1076029618764847, PubMed 29695176
Catheter-based left atrial appendage closure
Tidsskr Nor Laegeforen, 138 (7)
DOI 10.4045/tidsskr.17.0601, PubMed 29663763
Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials
High Blood Press Cardiovasc Prev, 25 (2), 151-158
DOI 10.1007/s40292-018-0258-z, PubMed 29663195
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Eur J Vasc Endovasc Surg, 55 (4), 457-464
DOI 10.1016/j.ejvs.2017.08.014, PubMed 29628287
Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI
Scand Cardiovasc J, 52 (4), 189-195
DOI 10.1080/14017431.2018.1458145, PubMed 29595340
Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants
Scand Cardiovasc J, 52 (3), 156-162
DOI 10.1080/14017431.2018.1453613, PubMed 29569500
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
PLoS Med, 15 (3), e1002538
DOI 10.1371/journal.pmed.1002538, PubMed 29558462
Cardiovascular pharmacotherapy and real-world data
Eur Heart J Cardiovasc Pharmacother, 4 (2), 65-66
DOI 10.1093/ehjcvp/pvy008, PubMed 29554294
How does the TRS 2°P score relate to real-world patients?
Eur Heart J Cardiovasc Pharmacother, 4 (2), 72-74
DOI 10.1093/ehjcvp/pvy004, PubMed 29554293
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction
Int J Cardiol, 258, 192-198
DOI 10.1016/j.ijcard.2018.01.077, PubMed 29544929
Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
Scand Cardiovasc J, 52 (3), 141-148
DOI 10.1080/14017431.2018.1450992, PubMed 29544369
Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
J Am Coll Cardiol, 71 (10), 1184-1186
DOI 10.1016/j.jacc.2017.12.057, PubMed 29519360
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
Heart Fail Rev, 23 (3), 303-323
DOI 10.1007/s10741-018-9685-0, PubMed 29516230
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Cochrane Database Syst Rev, 3 (3), CD008980
DOI 10.1002/14651858.CD008980.pub3, PubMed 29509959
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
Eur Heart J, 39 (19), 1672-1686f
DOI 10.1093/eurheartj/ehy066, PubMed 29509886
Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
Eur Heart J Qual Care Clin Outcomes, 2 (1), 52-57
DOI 10.1093/ehjqcco/qcv023, PubMed 29474586
Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
Eur J Prev Cardiol, 25 (7), 762-769
DOI 10.1177/2047487318760618, PubMed 29473463
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
Am Heart J, 197, 133-141
DOI 10.1016/j.ahj.2017.11.005, PubMed 29447773
New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden?
Blood Press, 27 (2), 62-65
DOI 10.1080/08037051.2018.1430504, PubMed 29447001
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Europace, 20 (5), 731-732an
DOI 10.1093/europace/eux373, PubMed 29438514
Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
Cytokine, 105, 17-22
DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
ESC Heart Fail, 5 (3), 292-301
DOI 10.1002/ehf2.12266, PubMed 29424484
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
J Am Heart Assoc, 7 (3)
DOI 10.1161/JAHA.117.007444, PubMed 29419390
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
Ann Neurol, 83 (3), 451-459
DOI 10.1002/ana.25165, PubMed 29394504
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
Eur Heart J, 39 (24), 2243-2251
DOI 10.1093/eurheartj/ehx760, PubMed 29365085
Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD
Int J Chron Obstruct Pulmon Dis, 13, 91-100
DOI 10.2147/COPD.S150034, PubMed 29339921
Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease
Matrix Biol, 75-76, 286-299
DOI 10.1016/j.matbio.2018.01.001, PubMed 29337052
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis
Circulation, 137 (3), 286-297
DOI 10.1161/CIRCULATIONAHA.117.031560, PubMed 29335288
Cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 4 (1), 1
DOI 10.1093/ehjcvp/pvx036, PubMed 29315398
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Europace, 20 (3), 395-407
DOI 10.1093/europace/eux318, PubMed 29300976
Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
Thromb J, 15, 30
DOI 10.1186/s12959-017-0153-1, PubMed 29299030
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
Eur Heart J, 39 (6), 464-473
DOI 10.1093/eurheartj/ehx730, PubMed 29281086
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
Scand Cardiovasc J, 52 (1), 1-3
DOI 10.1080/14017431.2017.1405069, PubMed 29202608
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
Thromb J, 15, 28
DOI 10.1186/s12959-017-0151-3, PubMed 29200971
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Rev Esp Cardiol (Engl Ed), 70 (12), 1082
DOI 10.1016/j.rec.2017.11.010, PubMed 29198432
Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!
Cardiology, 139 (1), 37-39
DOI 10.1159/000484345, PubMed 29186706
Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events
J Am Heart Assoc, 6 (12)
DOI 10.1161/JAHA.117.006709, PubMed 29180457
From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values
Eur Heart J, 38 (44), 3258-3271
DOI 10.1093/eurheartj/ehx643, PubMed 29177419
European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature
Eur Heart J, 38 (44), 3251
DOI 10.1093/eurheartj/ehx619, PubMed 29177414
Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction
J Electrocardiol, 51 (2), 195-202
DOI 10.1016/j.jelectrocard.2017.11.002, PubMed 29174706
Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
Resuscitation, 122, 41-47
DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
Cardiology, 139 (1), 17-24
DOI 10.1159/000481684, PubMed 29141241
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
Am Heart J, 193, 46-54
DOI 10.1016/j.ahj.2017.07.015, PubMed 29129254
Hypertension and cardiovascular risk: General aspects
Pharmacol Res, 129, 95-99
DOI 10.1016/j.phrs.2017.11.003, PubMed 29127059
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J, 39 (24), 2274-2281
DOI 10.1093/eurheartj/ehx625, PubMed 29126266
Patient engagement
Eur Heart J, 38 (42), 3114-3115
DOI 10.1093/eurheartj/ehx600, PubMed 29121227
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
J Am Heart Assoc, 6 (11)
DOI 10.1161/JAHA.117.006513, PubMed 29118031
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
Eur Heart J Cardiovasc Imaging, 19 (5), 544-552
DOI 10.1093/ehjci/jex159, PubMed 29106497
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (2), 218-223
DOI 10.1016/j.jelectrocard.2017.09.013, PubMed 29103621
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin
Stroke, 48 (12), 3266-3273
DOI 10.1161/STROKEAHA.117.017574, PubMed 29089455
Enlarged perivascular spaces are associated with health-related quality of life in patients with acute ischemic stroke
CNS Neurosci Ther, 23 (12), 973-979
DOI 10.1111/cns.12766, PubMed 29052954
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Arthritis Res Ther, 19 (1), 232
DOI 10.1186/s13075-017-1439-1, PubMed 29041979
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?
Blood Press, 26 (6), 319-320
DOI 10.1080/08037051.2017.1386539, PubMed 28975817
Heart failure with preserved ejection fraction
Tidsskr Nor Laegeforen, 137 (18)
DOI 10.4045/tidsskr.16.1068, PubMed 28972354
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Int J Cardiol, 249, 274-281
DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
J Am Coll Cardiol, 70 (14), 1760-1776
DOI 10.1016/j.jacc.2017.08.037, PubMed 28958334
Reply
J Hypertens, 35 (11), 2327-2328
DOI 10.1097/HJH.0000000000001526, PubMed 28953595
Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
DOI 10.1093/ehjci/jex178, PubMed 28950341
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
JRSM Cardiovasc Dis, 6, 2048004017729984
DOI 10.1177/2048004017729984, PubMed 28932392
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
DOI 10.1038/s41598-017-12372-w, PubMed 28931920
Long-term predictors of stroke in healthy middle-aged men
Int J Stroke, 13 (3), 292-300
DOI 10.1177/1747493017730760, PubMed 28929941
Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy
J Electrocardiol, 50 (6), 725-731
DOI 10.1016/j.jelectrocard.2017.08.019, PubMed 28918213
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 39 (2), 119-177
DOI 10.1093/eurheartj/ehx393, PubMed 28886621
Morphine in acute heart failure
J Thorac Dis, 9 (7), 1851-1854
DOI 10.21037/jtd.2017.06.129, PubMed 28839982
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
Data Brief, 14, 197-205
DOI 10.1016/j.dib.2017.07.033, PubMed 28795098
Neurohormonal Blockade in Heart Failure
Card Fail Rev, 3 (1), 19-24
DOI 10.15420/cfr.2016:22:2, PubMed 28785471
Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial
Transl Stroke Res, 9 (2), 120-129
DOI 10.1007/s12975-017-0548-0, PubMed 28770403
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials
Blood Press, 26 (5), 257-258
DOI 10.1080/08037051.2017.1357110, PubMed 28724313
PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts
Eur J Pharmacol, 812, 174-183
DOI 10.1016/j.ejphar.2017.07.014, PubMed 28697992
Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
Trials, 18 (1), 246
DOI 10.1186/s13063-017-1971-y, PubMed 28693599
Reduced HDL function in children and young adults with type 1 diabetes
Cardiovasc Diabetol, 16 (1), 85
DOI 10.1186/s12933-017-0570-2, PubMed 28683835
Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
Blood Press, 26 (6), 332-340
DOI 10.1080/08037051.2017.1346459, PubMed 28675304
Expertise: no longer a sine qua non for guideline authors?
J Hypertens, 35 (8), 1564-1566
DOI 10.1097/HJH.0000000000001435, PubMed 28657972
Expertise: No Longer a Sine Qua Non for Guideline Authors?
Hypertension, 70 (2), 235-237
DOI 10.1161/HYPERTENSIONAHA.117.09470, PubMed 28652465
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins
Cardiology, 138 (2), 122-132
DOI 10.1159/000475460, PubMed 28651249
Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection
BMC Infect Dis, 17 (1), 445
DOI 10.1186/s12879-017-2547-x, PubMed 28645263
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials
Int J Cardiol, 244, 59-66
DOI 10.1016/j.ijcard.2017.06.040, PubMed 28634037
Do real world data support and extend our ability to predict reverse remodelling following cardiac resynchronization therapy based on QRS morphology and width?
Eur J Heart Fail, 19 (9), 1152-1153
DOI 10.1002/ejhf.904, PubMed 28626904
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)
Circulation, 136 (13), 1193-1203
DOI 10.1161/CIRCULATIONAHA.117.027252, PubMed 28626088
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
Cardiorenal Med, 7 (2), 128-136
DOI 10.1159/000454933, PubMed 28611786
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
Mediators Inflamm, 2017, 5380638
DOI 10.1155/2017/5380638, PubMed 28596642
Prevention of heart failure mortality and hospitalizations in SPRINT, EMPA-REG, ALLHAT and HYVET: are diuretics the clue?
Blood Press, 26 (4), 193-194
DOI 10.1080/08037051.2017.1332478, PubMed 28566004
The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart
J Clin Med, 6 (5)
DOI 10.3390/jcm6050053, PubMed 28534817
Mechanisms of ECG signs in chronic obstructive pulmonary disease
Open Heart, 4 (1), e000552
DOI 10.1136/openhrt-2016-000552, PubMed 28533915
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study
J Am Heart Assoc, 5 (6)
DOI 10.1161/JAHA.116.003559, PubMed 28525886
Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension
Blood Press, 26 (6), 321-331
DOI 10.1080/08037051.2017.1320939, PubMed 28489464